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Abstract 
The work presented in this thesis focuses on developing a telemedicine system for better 
management of type1 diabetes in children and teenagers. The research and development of the 
system is motivated by the inadequate communication in the current system of management of 
the disease, which results in non-compliance of patients following the regimen. This non-
compliance generally results in uncontrolled blood glucose levels, which can result in 
hypoglycaemia, hyperglycaemia and later life health complications. This further results in an 
increase in health care costs. In this context, the thesis presents a novel end-to-end, low cost 
telemedicine system, WithCare+, developed in close collaboration between the University of 
Sheffield (Electronics & Electrical Engineering) and Sheffield Children’s Hospital. The system 
was developed to address the challenges of implementing modern telemedicine in type 1 
diabetic care with particular relevance to National Health Service children’s clinics in the 
United Kingdom, by adopting a holistic care driven approach (involving all stakeholders) based 
on specific key enabler technologies such as low cost and reconfigurable design. However, one 
of the major issues with current telemedicine system is non-compliance of the patients due to 
invasive procedure of the glucose measurement which could be clearly addressed by non-
invasive method of glucose measurement. 
Hence, the thesis also makes a contribution towards non-invasive glucose measurement using 
Near Infrared spectroscopy in terms of addressing the calibration challenge; two methods are 
proposed to improve the calibration of the Near Infrared instrument. The first method combines 
locally weighted regression and partial least square regression and the second method combines 
digital band pass filtering with support vector regression. The efficacy of the proposed methods 
is validated in experiments carried out in a non-controlled environment and the results obtained 
demonstrate that the proposed methods improved the performance of the calibration model in 
comparison to traditional calibration techniques such as Principal Component Regression and 
Partial Least Squares regression. 
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 Introduction Chapter 1
 
Diabetes mellitus, commonly known as “diabetes”, is a chronic disease which has been 
recognised for centuries. It is a metabolic disorder which affects the metabolism of 
carbohydrates and results in high blood sugar. The blood sugar is raised mainly for two 
reasons: either the pancreas does not produce enough insulin, which is known as type 1 
diabetes, or because cells do not respond to insulin produced by the pancreas, which is 
referred to as type 2 diabetes. The other known form of diabetes is gestational diabetes, 
which occurs during the later stages of pregnancies in some women but normally 
disappears after birth [1,2]. 
Type 1 diabetes (also referred to as Insulin Dependent Diabetes Mellitus) is a form of 
diabetes  that results from the autoimmune destruction of insulin-producing beta cells of 
the pancreas, which results in the body not producing insulin [1]. This form of diabetes 
can affect people of any age, but is more prevalent in children or young adults and the 
reason for its occurrence is not fully understood. There is no known cure for type 1 
diabetes, however the disease can be managed. Since this form of diabetes generally 
occurs in children, more challenges are faced in managing the disease. 
1.1 Current Management of Type 1 Diabetes 
  The management of type 1 diabetes involves the measurement of blood glucose level 
(BGL) and insulin intake 3-4 times a day by the patient or caregiver. In addition, 
patients have to take care of their diet and exercise to maintain their BGL at near normal 
levels. The patient normally records their BGL before meals, and if it is within the 
normal range, the patient injects insulin in proportion to the carbohydrates intake. If the 
glucose level is higher than expected, the patient injects extra insulin, which is known 
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as bolus insulin, to avoid any occurrence of hyperglycaemia. On the other hand, if the 
glucose level is low, which is normally the case when the patient wakes up in the 
morning, they eat something to bring the glucose level back within the normal range 
and avoid the occurrence of hypoglycaemia. 
Patients generally need to prick their finger with a needle and use a glucometer to 
record BGL. They are expected to record their glucose readings and insulin intake in a 
diary provided by the health-care centre. This process is repeated 3-4 times daily by the 
patient from the onset of the disease for the rest of their life.  
The patient has to visit the healthcare centre usually every 3 months for a routine 
examination. During this visit, the glycosylated haemoglobin or glycated haemoglobin, 
(also known as haemoglobin A1c or HbA1c) of the patient is measured in the 
laboratory, and this identifies the average plasma glucose concentration. This measure 
provides the clinician with a much better indication of long term glycaemic control of 
the patient, as it reflects the mean glucose level over the previous period, which is 
usually 3 months. A team of health-care professionals, i.e. the nurse, doctor and 
dietician, is involved during the visit. This team advises the patient based on glucose 
levels, the insulin intake from the patient diary records as well as the HbA1c laboratory 
report. Higher amounts of HbA1c indicate poor control of blood glucose levels, which 
have been associated with cardiovascular disease, nephropathy, and retinopathy. The 
clinician can also advise the patient to visit the ophthalmologist, cardiologist, 
nephrologist and  psychiatrist from time to time if needed [1, 2].  
 The healthcare providers face a number of challenges in the current system of 
management of the disease, especially in the context of teenagers. The issue with 
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adolescents is that they are in a transition period where they take over the management 
of BGL from their parents. As they grow older they may exert more independence and 
may not adhere as strictly to the desired regime as they did as children. Often teens do 
not take measurements regularly, and their parents do not have this information. This 
leads to uncontrolled BGL, which if ignored can lead to episodes of hyperglycaemia [1]. 
 The process discussed in the section above involves communication on the part of the 
patient in terms of the daily glucose measurements and insulin intake, and feedback 
from the diabetic team to the patient in terms of glucose intake, exercise and dietary 
advice. Inadequate communication and working with uncertainty is generally a serious 
problem for all fields, but is particularly serious in the field of healthcare. To improve 
the quality of everyday life of the patient, there needs to be a low cost communication 
channel between members of the team on a daily basis. The team can consist of the 
patient, doctor, nurse, clinician, dietician as well as friends and parents. The results of 
the team effort are dependent on effective communication, which can result in better 
control of glucose levels. The Diabetes Control and Complications Trial (DCCT) 
concluded that maintaining controlled blood glucose levels can reduce the risk of long-
term diabetic complications [3].The current management of the disease clearly lacks the 
communication among the members of the diabetic team on a daily basis, even in 
technologically advanced places of the world.  
A well-engineered, low-cost, reliable telemedicine system with two-way 
communication is an ideal candidate for addressing the management issues of type 1 
diabetes. The next section explains how such a system can help to improve the 
management of type 1 diabetes. 
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1.2 Telemedicine for Effective Management of Type 1 Diabetes 
Researchers have evaluated and are evaluating the use of communications technology in 
the implementation and performance of telemedicine activities, and have examined the 
impact of telemedicine on medical care in terms of cost, quality and access [4-7]. 
Telemedicine has become a growing new interdisciplinary field, which will eventually 
contribute to improving the quality of healthcare for everyone. However, successful 
implementation of this vision depends not only on innovative telemedicine applications 
but also on computing and networking technical readiness. Furthermore, many ethical, 
social and political problems arising in telemedicine need technical solutions.  
Most of these systems, however, suggest solutions based on the assumption that patients 
are motivated to take their blood glucose measurements as per the advice of health-care 
providers. The challenges of type 1 diabetic care for health-care providers, especially 
among teenagers, are much more complicated from those of type 2 patients [8,9].  Thus 
it is pertinent that more studies are conducted to demonstrate that telemedicine could 
improve clinical outcomes for type 1 diabetes in children and young adults, before it can 
be adopted widely in healthcare. 
 The recent advances in communications technologies, information technology and 
miniaturisation of electronic components offer considerable scope to refine and develop 
the concept of telemedicine into a clinically useful tool where the technology is used 
more pervasively to monitor and manage chronic conditions such as type1 diabetes. The 
system must be care driven, low cost and holistic in its approach. It must also be 
ubiquitous, secure and require minimal effort by the patient and clinician in order to be 
effective but at the same time should overcome the perception of loss of privacy. 
Another important feature of the technology is that it must be easily reconfigurable to 
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support a range of sensors and communication platforms. It is also essential to 
understand what technological innovations may be acceptable by both patients and 
health service providers and how widely they may or may not be embraced. These 
issues are crucial to the translation of telemedicine into clinical care in particular for 
chronic conditions such as type 1 diabetes, specifically in teenage patients where 
engagement with treatment strategies is not always forthcoming.  
In this context, this thesis presents a novel end-to-end telemedicine system, WithCare+, 
developed in close collaboration between the University of Sheffield (Electronics & 
Electrical Engineering and Psychology departments) and Sheffield Children’s Hospital 
and targeted at type 1 diabetes management in children and young adults. The system 
was developed to address the challenges of implementing modern telemedicine in type 
1 diabetic care with particular relevance to NHS children’s clinics in the UK, by 
adopting a holistic care driven approach (involving all stakeholders) based on specific 
key enabler technologies such as privacy aware security, low power, low cost and 
reconfigurable design. Although WithCare+ can resolve many difficulties in 
monitoring, feedback and management of patient care, there still remains one challenge 
which cannot be addressed by the current telemedicine system. This is the issue of the 
finger prick method involved in the measurement of glucose 3-4 times on a daily basis 
from the onset of disease for the rest of life. This method is clearly inconvenient and 
results in many patients not adhering to the required daily measurements.   
This challenge can be addressed by non-invasive glucose measurement. Although the 
instrumentation for the non-invasive glucose measurement is available, the calibration 
of the instrument for the determination of glucose certainly remains one of the 
challenges for clinical translation of the technology.  Near infrared spectroscopy (NIR), 
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due to its advantages such as low water absorbance, little or no sample preparation, and 
high signal to noise ratio (SNR) has been recognised as one of the most promising 
technologies for non-invasive glucose monitoring [10-13].  
The aim of non-invasive glucose monitoring based on NIR spectroscopy is to transmit a 
limited band of radiation to a selected region of the body. The light intensity of 
transmitted or reflected radiation is changed as a function of the tissues and is correlated 
with the variation of the concentration of glucose. However, determination of the 
concentration of glucose from NIR spectra is not easy, as the collected spectra are 
affected by instrument noise, baseline variations and temperature variations. The 
collected spectra are also weak in intensity, broad and overlapped. The challenge of 
quantitative data analysis is addressed by multivariate calibration methods augmented 
by signal pre-processing techniques.    
1.3 Research Questions  
1) How to design a telemedicine system which will be adopted by the healthcare 
professionals at Sheffield Children’s Hospital for management of type 1 
diabetes. 
2) How to improve the communication between the members of a diabetic team i.e. 
the patients, clinician, dietician and nurses involved in management of type 1 
diabetes.  
3) How to improve the multivariate calibration techniques for determination of 
glucose concentration from NIR spectra. The aim of this preliminary study is to 
contribute towards clinical translation of the non-invasive glucose measurement. 
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1.4 Thesis Aims and Scope 
The aim of this thesis is to design, develop and implement “WithCare+”, for remote 
monitoring and better management of type 1 diabetic patients by exploiting the current 
advances in telecommunication, information technology and mobile technology. The 
further aim of the thesis is the preliminary study towards the vision of future 
WithCare+, where the patient can measure their BGL non-invasively without pricking 
the skin. Researchers are working on different technologies to achieve the goal of non-
invasive glucose measurement. However, the scope of the thesis is limited to 
development of the robust calibration models for Fourier transform near infrared (FT-
NIR) spectrometer. The efficacy of the proposed models is validated for the 
determination of glucose concentration from NIR spectra of an aqueous solution 
composed of glucose, urea and triacetin in a phosphate buffer solution. The 
concentrations of the components are selected to be within their physiological range in 
blood and the experiments were carried out without controlling the environmental 
conditions such as temperature and humidity, to show that the proposed models can 
effectively suppress most of the experimental variation.   
1.5 Key Contributions 
The motivation for this study was to look into the various aspects where technology can 
be exploited in an innovative way to help children suffering from diabetes. The main 
contribution of this thesis is the design, development and testing of a telemedicine 
system. The new system was designed based on the requirements gathered from the 
diabetic team at Sheffield Children’s Hospital. Initially the system was developed on 
Windows operating system using C# for developing business logic, asp.net for 
developing the user interface and SQLServer to develop the database. This version was 
developed with the view that the information technology (IT) department of the NHS 
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may prefer to integrate the Windows based system. Later on, the system was developed 
using open source technology such as PHP, PERL and MySQL on a Linux operating 
system (Ubuntu) which hosts an Apache Web server keeping in view the advantages 
offered by the open source technology. 
The author has also contributed in designing and developing the proof of concept for 
Bluetooth communication over the radio frequency communication (RFCOMM) 
channel profile of Android based smart phones, which are the backbone of WithCare+ 
communication. The need for this approach arose due to the fact that the native serial 
port profile (SPP) does not exist in smart phones. The success of this proof of concept 
led to the implementation of Bluetooth communication between WithCare+ and 
Android. The same concept is extended to other platforms such as Blackberry. 
This thesis also made a contribution in the area of non-invasive glucose measurement 
by developing novel calibration models by exploiting the advances in machine learning 
and signal processing, which can not only benefit the type 1 diabetic people but would 
directly help patients with any other type of diabetes as well. In this study, two novel 
regression techniques were proposed. The first method combines the locally weighted 
regression (LWR) with partial least squares regression (PLSR) to improve the 
performance of PLSR model. The second method couples the digital band pass filter 
with the support vector regression to improve the quality of collected spectra and 
develop the calibration model with better generalisation. These models were validated 
for the determination and prediction of glucose concentration from NIR spectra of a 
mixture composed of urea, triacetin, and glucose. The results when compared with 
traditional calibration techniques such as principal component regression (PCR) and 
PLSR demonstrate that the proposed techniques improved the performance of 
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calibration models and can be validated for determination of glucose concentration from 
blood serum in future. 
1.6 Thesis Structure 
Chapter 2 presents an introduction to diabetes, its economic importance and the need for 
a telemedicine system for remote monitoring of BGL of type 1 diabetic patients. The 
chapter further discusses state-of-the-art technology in the domain of telemedicine 
systems. 
Chapter 3 explains the system architecture, design, and implementation of the proposed 
telemedicine system “WithCare+”. Here the technologies selected for development and 
testing are also presented.  The difficulties faced during the clinical trial of the system 
are mentioned. 
Chapter 4 presents an overview of non-invasive glucose measurement and describes the 
near infrared spectroscopy as the choice for the non-invasive glucose measurement.  
The chapter further explains the theory of pre-processing and calibration methods for 
NIR data. In addition, the experimental setup for data collection is explained. The model 
development with results of proposed novel calibration technique is explained as well. 
Chapter 5 gives an overview of support vector regression and digital band pass filtering 
as a pre-processing calibration technique. In addition, the model development with 
results of proposed novel calibration technique is explained. 
Chapter 6 concludes this report. The recommendations are presented here and areas for 
further work are identified. 
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1.7 Publications 
1.7.1 Book Chapters in Edited book  
1. BILAL AHMAD MALIK AND MOHAMMED BENAISSA, “Glucose 
Chemistry” in Preedy, Victor R., ed. Dietary Sugars: Chemistry, Analysis, 
Function and Effects. Vol. 3. Royal Society of Chemistry, 2012. ISSN 2045-1695 
DOI:10.1039/9781849734929-00077. 
2. MOHAMMED BENAISSA, AMNEH MBAIDEEN AND BILAL AHMAD 
MALIK “Assay of Glucose Using Near Infrared (NIR) Spectroscopy” in Preedy, 
Victor R., ed. Dietary Sugars: Chemistry, Analysis, Function and Effects. Vol. 3. 
Royal Society of Chemistry, 2012. . ISSN 2045-1695,  
DOI: 10.1039/9781849734929-00286. 
1.7.2 Paper Publications  
1. B.Malik and M.Benaissa, "Determination of glucose concentration from near-
infrared spectra using locally weighted partial least square regression," in 
Engineering in Medicine and Biology Society (EMBS), 2012 Annual 
International Conference of the IEEE, 2012, pp. 6169-6171. Conf Proc IEEE 
Eng Med Biol Soc; 2012;2012:6169-71 PMID: 23367337. 
2. Bilal Malik and M.Benaissa, “Determination of glucose concentration from 
near-infrared spectra using support vector regression” presented at International 
Conference on New Trends in Chemometrics and Applications at Ankara 
University, Turkey. 
3. Bilal Malik, Krishna and M.Benaissa, “Determination of glucose concentration 
from near-infrared spectra using support vector regression coupled with digital 
band pass fitler,” submitted to Journal of Chemometrics.  
4. M.Benaissa, B.Malik, A.Kanakis, and N.P.Wright, "Tele-healthcare for diabetes 
management: A low cost automatic approach," in Engineering in Medicine and 
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Biology Society (EMBS), 2012 Annual International Conference of the IEEE, 
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5. A.Kanakis, B.Malik, and M.Benaissa, "Low cost universal remote patient 
monitoring system," in High Performance Computing and Communication & 
2012 IEEE 9th International Conference on Embedded Software and Systems 
(HPCC-ICESS), 2012 IEEE 14th International Conference on, 2012, pp. 1587-
1591.  
6.  Mohammed Benaissa, Neil Wright, Anastasios Kanakis, Bilal Malik and 
Barbara Johnson, “WithCare+ System: A holistic, care-driven approach to 
telemedicine for type-1 diabetes in children and young adults” 3rd International 
Conference on Wireless Mobile Communication and Healthcare November 21–
23, 2012 Paris, France. 
7. Krishna Chaitanya, Bilal Malik, Mohammed Benaissa, “Prediction of glucose 
concentration from near infrared spectra using local linear embedded regression 
combined with a digital band pass filter”. Conferentia Chemometrica 2013 Sopron, 
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 Background Chapter 2
 
 
This chapter explores the literature that focuses on diabetes mellitus, its harmful effects, 
and associated economic costs, and examines state-of-the-art technology in the area of 
telemedicine systems specifically designed to improve the diabetic care. Although 
diabetes insipidus has common symptoms with diabetes mellitus, they are entirely two 
different conditions with unrelated mechanisms. 
2.1 Overview of Diabetes Mellitus 
2.1.1 Diabetes Mellitus Concepts  
 Diabetes mellitus, commonly known as Diabetes, is one of the major chronic diseases 
associated with abnormally high levels of glucose (sugar) in blood, due to the reason 
that either the pancreas does not produce enough insulin or cells do not  respond to the 
produced insulin [1,2]. Insulin is a naturally occurring hormone needed to transform 
sugar into energy required for daily life. The symptoms associated with high blood 
sugar are polyuria (frequent urination), polydipsia (increased thirst) and polyphagia 
(increased hunger). The complications of diabetes constitute a major health problem in 
modern societies worldwide [1, 2].  
 Diabetes is a serious chronic disease which causes a high rate of morbidity and 
mortality all over the world. Diabetes is ranked seventh in the list of diseases for cause 
of death [3]. In 2012, it has been reported that this disease affects about 371 million 
people across the globe and it is expected by the year 2030 that disease will increase by 
51% [4]. The greatest increase in occurrence is, however, expected to occur in Asia, 
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where it is predicted that most patients will probably be found by 2030. According to 
the International Diabetes Foundation (IDF) in 2011, China with the diabetic population 
of 90 million people topped the list of countries, whereas India with 60 million diabetic 
population ranks second [4]. The average age of onset is 42.5 years. The high incidence 
is attributed to a combination of genetic susceptibility plus the adoption of a high-
calorie, low-activity lifestyle by India's growing middle class [5]. The increase in 
incidence of diabetes in developing countries follows the tendency of urbanization and 
changes in lifestyle [6].   
2.1.2 Types of Diabetes 
There are three major types of diabetes:  
 Type-1 Diabetes  also known as  insulin dependent diabetes mellitus-IDDM 
 Type 2 Diabetes  also known as non-insulin dependent diabetes mellitus-
NIDDM  
 Gestational Diabetes Mellitus  
Other rare types of diabetes include those caused by genetic conditions, surgery, drug 
use, malnutrition, infections, and other illnesses. 
2.1.3 Type-1 Diabetes (Insulin Dependent Diabetes Mellitus-IDDM)  
Type 1 diabetes is an auto-immune disease where the body's immune system destroys 
the insulin-producing beta cells in the pancreas, leading to insulin deficiency. This type 
of diabetes, also known as juvenile-onset diabetes, accounts for about 10% of all people 
with the disease. There is no known preventive measure against this type of disease. It 
can appear at any age, although common under 30, and is triggered by environmental 
factors such as viruses, diet or chemicals as well as genetic factors. At the onset of the 
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disease most patients are otherwise healthy and of normal weight. People with type 1 
diabetes must inject themselves with insulin several times a day and follow a careful 
diet and exercise plan. Patients normally respond well to insulin, particularly at the early 
stages [1,2]. 
Type 1 diabetes is accompanied by irregular and unpredictable hyperglycemia, ketosis, 
sometimes serious hypoglycemia, eye infections, endocrinopathies and erratic 
absorption of dietary carbohydrates due to many different reasons[1,2].  
 2.1.4 Type 2 Diabetes (Non-Insulin Dependent Diabetes Mellitus-NIDDM)  
This type is more common usually accounting for about 90% of cases. It is diagnosed in 
adults but young people can also suffer from this disease. In this type there is a reduced 
sensitivity to Insulin on a cellular level in addition to inadequate levels of insulin 
production by the pancreas. It is the most serious type of diabetes; often people do not 
know they are suffering with it. Three major causes of type 2 diabetes are lifelong bad 
diet, an inactive or sedentary lifestyle, and being overweight. Type 2 diabetes is 
becoming more common due to risk factors like older age, obesity, lack of exercise, 
family history of diabetes [8]. Some changes in lifestyle, importantly increase in 
physical activities  and modest weight reduction can reduce the chances of suffering 
from type 2 diabetes by as much as 58% [9]. Use of metformin (a drug used as a 
treatment for type 2 diabetes) along with a good lifestyle and a healthy diet, reduces the 
risk of development of type 2 diabetes by 31%, but metformin is not effective in 
patients above 60 years of age [10]. Several former terms like childhood-onset diabetes, 
juvenile diabetes, and insulin-dependent diabetes mellitus (IDDM) have been replaced 
by the term ‘type 1  diabetes’;  ‘type 2 diabetes’ has also replaced former terms like 
obesity-related diabetes, noninsulin-dependent diabetes mellitus (NIDDM) and adult-
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onset diabetes. Table 2.1 compares some of the characteristics of type 1 and type 2 
diabetes. 
Table 2.1 General Characteristics of Types 1 And 2 Diabetes Mellitus  
Characteristics 
 
Type 1 Type 2 
 
Age at onset 
 
Most commonly < 30 yr 
 
Most commonly > 30 yr 
 
Associated obesity No Very common 
Ketoacidosis Yes No 
Twin concordance <=50% >90% 
Associated with specific 
HLA-D Antigens 
Yes No 
Islet cell antibodies at 
diagnosis 
Yes No 
Islet pathology 
Insulitis, selective 
loss of most β 
cells 
Smaller, normal-appearing 
islets; amyloid (amylin) 
deposition is common 
Prone to develop  diabetes 
Complications 
Yes Yes 
Hyperglycemia responds to 
oral antihyperglycemic drugs 
No Yes, initially in many patients 
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2.1.5 Gestational Diabetes Mellitus  
 Gestational Diabetes Mellitus (GDM) is high blood glucose that develops in 25% of 
women during pregnancy. But it disappears once the baby is born. Gestational diabetes 
is fully treatable, but requires careful medical supervision throughout the pregnancy. 
About 20%–50% of affected women develop type 2 diabetes later in life. Treatment of 
gestational diabetes reduces serious perinatal morbidity and may also improve the 
woman’s health-related quality of life. On the other hand, untreated gestational diabetes 
can damage the health of the foetus or mother. Risks to the baby include macrosomia 
(high birth weight), congenital cardiac and central nervous system anomalies, and 
skeletal muscle malformations. Increased foetal insulin may inhibit foetal surfactant 
production and cause respiratory distress syndrome. Hyperbilirubinemia may result 
from red blood cell destruction. In severe cases, perinatal death may occur, most 
commonly as a result of poor placental perfusion due to vascular impairment. Labour 
induction may be indicated with decreased placental function. A Caesarean section may 
be performed if there is marked foetal distress or an increased risk of injury associated 
with macrosomia, such as shoulder dystocia [11-13]. 
In 2008, a study reported that the number of American women entering pregnancy with 
pre-existing diabetes is increasing at an alarming rate [14]. This is particularly 
problematic as diabetes raises the risk of complications during pregnancy, as well as 
increasing the potential for the children of diabetic mothers to become diabetic in the 
future [11-13]. Other forms of diabetes mellitus include congenital diabetes, which is 
due to genetic defects of insulin secretion, cystic-fibrosis related diabetes, steroid 
diabetes induced by high doses of glucocorticoids, and several forms of monogenic 
diabetes. 
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2.1.6 Metabolic Mechanisms 
All forms of diabetes have been treatable since insulin became available in 1921, and 
type 2 diabetes may be controlled with medications or diet alone. Insulin is the principal 
hormone that regulates uptake of glucose from the blood into most cells (primarily 
muscle and fat cells, but not central nervous system cells). Therefore, deficiency of 
insulin or the insensitivity of its receptors plays a central role in all forms of diabetes 
mellitus. 
Both type 1 and 2 are chronic conditions that usually cannot be cured. Pancreas 
transplants have been tried with limited success in type 1 DM; gastric bypass surgery 
has been successful in many with morbid obesity and type 2 DM. Gestational diabetes 
usually cures itself after delivery. Diabetes without proper treatments can cause many 
complications. Acute complications include hypoglycemia, diabetic ketoacidosis, or 
nonketotic hyperosmolar coma. Serious long-term complications include cardiovascular 
disease, chronic renal failure, and diabetic retinopathy (retinal damage). Thus it is 
important that diabetes must be managed well.  
Humans are capable of digesting some carbohydrates, in particular those most common 
in food. Some disaccharides such as sucrose are converted within a few hours to simpler 
forms, most notably the monosaccharide glucose, the principal carbohydrate energy 
source used by the body. The rest is passed on for processing by gut flora largely in the 
colon. Insulin is released into the blood by beta cells (β-cells), found in the islets of 
Langerhans in the pancreas, in response to rising levels of blood glucose, typically after 
eating. Insulin is used by about two-thirds of the body’s cells to absorb glucose from the 
blood for use as fuel, for conversion to other needed molecules, or for storage. 
2-7 
 
Insulin is also the principal control signal for conversion of glucose to glycogen for 
internal storage in liver and muscle cells. Lowered glucose levels result both in the 
reduced release of insulin from the β-cells and in the reverse conversion of glycogen to 
glucose when glucose levels fall. This is mainly controlled by the hormone glucagon, 
which acts in the opposite manner to insulin. Glucose thus forcibly produced from 
internal liver cell stores (as glycogen) re-enters the bloodstream; muscle cells lack the 
necessary export mechanism. Normally, liver cells do this when the level of insulin is 
low (which normally correlates with low levels of blood glucose). 
Higher insulin levels increase some anabolic (building up) processes, such as cell 
growth and duplication, protein synthesis, and fat storage. Insulin (or its lack) is the 
principal signal in converting many of the bidirectional processes of metabolism from a 
catabolic to an anabolic direction, and vice versa. In particular, a low insulin level is the 
trigger for entering or leaving ketosis (the fat-burning metabolic phase). 
If the amount of insulin available is insufficient, or cells respond poorly to the effects of 
insulin (insulin insensitivity or resistance), or the insulin itself is defective, then glucose 
will not have its usual effect. Hence, it will not be absorbed properly by those body cells 
that require it, nor will it be stored appropriately in the liver and muscles. The net effect 
is persistent high levels of blood glucose, poor protein synthesis, and other metabolic 
derangements, such as acidosis. 
When the glucose concentration in the blood is raised beyond its renal threshold (about 
10 mmol/L, although this may be altered in certain conditions, such as pregnancy), 
reabsorption of glucose in the proximal renal tubuli is incomplete, and part of the 
glucose remains in the urine (glycosuria). This increases the osmotic pressure of the 
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urine and inhibits reabsorption of water by the kidney, resulting in increased urine 
production (polyuria) and increased fluid loss. Lost blood volume will be replaced 
osmotically from water held in body cells and other body compartments, causing 
dehydration and increased thirst. 
2.1.7 Diabetes in the UK 
It has been reported in 2011 that there are 2.9 million people in the UK who have been 
diagnosed with diabetes and it is estimated that this figure will increase to five million 
by 2025 [7]. Type 1 diabetes is more prevalent in children and the UK ranks fifth 
highest in the world for the rate of children diagnosed with type 1 diabetes. Finland, 
Sweden, Saudi Arabia and Norway have higher rates as compared to the UK as per the 
available data [7]. UK charities such as Diabetes UK and the Juvenile Diabetes 
Research foundation (JDRF) warn that it is important that people are aware of 
symptoms of type 1 diabetes because if left undiagnosed and untreated, it can lead to 
serious illness and even death. There are about 23,000 children under the age of 17 with 
diabetes in England and 97% of them have type 1 diabetes. The peak age for diagnosis 
is between 10 to 14 years of age [7].   
2.1.8 Related Complications 
Diabetes-related complications include: 
 Microvascular diseases (e.g. retinopathy, blindness, nephropathy, and kidney 
failure). 
 Macrovascular diseases (coronary heart disease, stroke, peripheral vascular 
disease and lower-extremity amputation). 
 Influenza and pneumococcal infections. 
 Eye complications.  
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2.1.9 Economic Importance of Diabetes 
Diabetes mellitus is a public health concern of considerable economic importance due to 
its chronic nature, increasing global prevalence, and the serious complications 
associated with long-term disease duration. Diabetes imposes large economic burden on 
national healthcare systems and affects both national economies, individuals and their 
families. Indirect costs of disease include lost productivity caused by morbidity, 
disability, and premature mortality. The intangible costs of diabetes are the reduced 
quality of life for people with diabetes due to stress, pain, and anxiety. It is estimated 
that National Health Service (NHS) spends £10 billion on diabetes, which is about 10% 
of the NHS budget and currently the total cost (direct costs and indirect costs) is £23.7 
billion [15-18]. Data from Europe indicate that the healthcare expenditure for patients 
with diabetes mellitus is significantly higher for comparable patients without this 
disease. These and other studies also suggest that the majority of such ‘excess’ costs can 
be attributed to diabetes-related complications [15-18].  
2.2 Monitoring and Management of diabetic patients  
Diabetes mellitus is a chronic disease which cannot be cured except in very specific 
situations. So, the disease needs to be managed by the patients in order to avoid 
complications. Generally, the goal of good management is to keep blood sugar levels 
close to normal (“euglycemia”), without causing low levels of blood sugar known as 
hypoglycaemia or high levels of blood sugar known as hyperglycaemia. Proper diabetes 
management involves close monitoring of glucose levels in the blood, insulin intake (for 
insulin dependent patients), diet and exercise. Blood glucose monitoring refers to the 
on-going measurement of blood glucose levels and is typically done using a portable 
device called a glucometer.  
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2.2.1 Operation of a Glucometer 
A glucometer is a battery operated device used by diabetic patients for measurement of 
their blood glucose concentration from home. Most of the glucometers in the market use 
an electrochemical method for measurement of glucose concentration in the whole 
blood. In these meters a test strip acts as a glucose sensor; a small amount of blood 
drawn from the finger of a patient is sucked by the capillary on the test strip. An 
electrochemical reaction takes place between the glucose in the blood with an enzyme 
electrode containing glucose oxidase (or dehydrogenase). The glucose in the blood 
sample reacts with the glucose oxidase to form gluconic acid, which then reacts with 
ferricynaide to form ferrocynaide. The electrode oxidizes the ferrocyanide, and this 
generates a current directly proportional to glucose concentration. Most of the 
glucometers display results between 20 to 600 mg/dL (1.1-33.3) mmol/L in a small 
window and it generally takes 3 to 60 seconds for measurement depending on the model 
of the glucometer. 
Monitoring vital parameters from a patient with a chronic condition enables the general 
practitioner (GP) or healthcare provider to intervene before the patient’s state of health 
becomes critical thereby saving lives while avoiding unnecessary extra costs of 
emergency treatment. Telemedicine is an ideal candidate to address the challenges of 
type 1 diabetes management. 
2.3 Telemedicine 
Recent advances in information and communication technologies (ICTs) such as 
computers, the internet, and cell phones are changing how people communicate with 
each other, seek and exchange information.  There is great potential of adapting these 
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advances in ICT to address contemporary global health problems such as access, 
equality, quality and cost-effectiveness. 
Telemedicine literally means “healing at a distance” [19], which implies the utilization 
of ICT to support healthcare by overcoming the classical barriers of time and distance. 
It generally includes, but is not limited to, transmission of patient data to healthcare 
providers at a distance and after the analysis of data by the server software, immediate 
feedback is sent to the patient by the software or the healthcare professional via the 
different channels of communication available in the system. It is recognized that there 
is no definitive definition of telemedicine: Sood (2007) found 104 peer-reviewed 
definitions of the word [20]. However, the World Health Organization has adopted the 
following definition: 
“The delivery of healthcare services, where distance is a critical factor, by all 
healthcare professionals using information and communication technologies for 
the exchange of valid information for diagnosis, treatment and prevention of 
disease and injuries, research and evaluation, and for the continuing education of 
healthcare providers, all in the interests of advancing the health of individuals 
and their communities.” [19] 
Some authors differentiate between terms ‘telehealth’ and ‘telemedicine’, with the latter 
limited to service provided by clinicians only, and the former service delivered by 
health professionals in general. However, within the scope of this thesis, these terms are 
used interchangeably and are synonymous. 
The multiple descriptions of telemedicine highlight that it is an evolving technology, as 
it assimilates both changing health needs and rapid advances in ICT. The main purpose 
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of telemedicine is to improve interaction between patients and their healthcare provider 
in order to achieve desired clinical outcomes and reduce monitoring and management 
costs. The following components are integral to telemedicine: 
 A process or a device for accurate patient data collection in digital format. 
 Secure transmission of the collected patient data securely to a remote server. 
 A set of protocols to ensure system security between client (patient unit) and 
server. 
 Different channels of communication to enhance present level of communication 
among the stakeholders.  
 A facility for immediate alert to healthcare professionals in case of abnormal 
behaviour. 
 Facilities that enable healthcare professionals to send therapeutic advice to the 
patients in different formats, such as text message, email or video link.  
Although there has been renewed research and commercial interest in the area of 
telemedicine over the last decade, its inception can be traced back to middle of the 19th 
century [21]. Later developments include the transmission of electrocardiograph data 
over telephone wires in the early 20th century [22] and developments in the military and 
space sectors in 1960s that started telemedicine in its modern form [21,23]. Recent 
advances in ICT and its usage by the general population has been the main driving force 
for emerging trends in telemedicine in both developed and developing nations [24]. 
A telemedicine application generally involves the transmission of data from a distant 
location and interactions between healthcare professionals and other health 
professionals or between healthcare professionals and patients. A telemedicine 
2-13 
 
application is generally classified into two basic types, asynchronous (store-and-
forward) and synchronous. The former involves exchange of pre-recorded data between 
stakeholders at different times as in case of email, whereas, in the latter communication 
takes place in real time with an immediate exchange of information between 
individuals, such as in videoconferencing. Both of these approaches can transmit data 
using different media such as text messages, audio, video or still images and can be 
applied to a wide array of services in diverse settings such as teleradiology, 
telepathology and teledermatology care [21,24].  
2.3.1 Telemedicine for Diabetic Management 
Telemedicine can be utilized as a support tool for better management of diabetes by 
improving communication among the stakeholders of diabetes management team. 
Telemedicine has an impact on different aspects of patient care such as the 
informational, clinical, behavioural, structural, and economic. The informational impact 
is an improvement in the quality of information due to the digital transmission, as 
compared to handwritten records in a diary, which may be forgotten at home on 
appointment days or inadvertently left incomplete. Frequent communication of 
information, instructions and feedback can have a clinical impact in terms of lowered 
glycated haemoglobin (HbA1C) levels. The behavioural impact involves reminders and 
frequent therapy adjustments, leading to greater patient empowerment and education. 
Patients may need to come in to the physician's office for fewer visits, which will have a 
structural impact. The economic impact of telemedicine is poorly understood at this 
time and needs more studies to draw any conclusions. Whitten et al. [25] from their 
study on the cost effectiveness of telemedicine concluded that there is presently no 
persuasive evidence of cost benefits of telemedicine in comparison to normal care. 
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2.3.2 Goals of Telemedicine 
The main goals of using a telemedicine system are to collect and transmit medical data 
securely from a patient at a distant location to a server managed by a healthcare 
provider. The data received at the server is analysed after passing security checks and 
appropriate feedback is sent to the patient or caregiver. This process of two way 
communication enhances the interaction among different stakeholders involved with the 
management of the disease, which can lead to an improvement in clinical outcomes 
[26]. 
2.3.3 Benefits of Telemedicine 
A successful telemedicine program is robust, effective, user-friendly, and cost-effective. 
A robust telemedicine system helps the transmission of patient data from remote site to 
the server of the healthcare provider by maintaining data integrity. A robust system will 
include time stamping of patient data to avoid data duplication and a protocol between 
the patient unit and server to manage security. A telemedicine system can be classified 
as effective if it is adopted by the healthcare providers and improves clinical outcomes. 
The clinical outcomes for diabetes patients can be measured by the variation in 
glycaemic value, number of hypoglycaemic events, emergency room visits for diabetes-
related events and A1C levels. The effectiveness of the system can be measured by 
patient and healthcare provider satisfaction levels. Telemedicine management of the 
disease could be cost-effective in the long run but initial costs may be high. Thus 
analysis of the cost effectiveness must not be based on short term goals and must 
instead take into account long-term benefits to compare it with the conventional cost of 
care [27]. 
A user-friendly telemedicine system with the above benefits will overcome the 
problems that have hindered the adoption of these systems [26,28].  
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2.3.4 Barriers to the Adoption of Telemedicine 
Considerable barriers from both healthcare providers and patients currently limit the 
penetration of telemedicine to deliver routine services, both in industrialized and 
developing countries. Both technical and systemic obstacles exist, such as fear of 
technology or fear of change, privacy concerns or a lack of training in ICT. 
Furthermore, in the case of diabetic management, telemedicine systems may fail to 
accommodate the brand of glucometer preferred by the patient. These barriers on the 
part of health stakeholders of diabetes deter the adoption of current telemedicine 
systems [23,26,27,29]. 
The lack of studies demonstrating persuasive evidence for the cost benefits of 
telemedicine in comparison to conventional care is also a barrier to convincing policy-
makers to invest in telemedicine [27]. The other major obstacle is the absence of 
international legal framework and the risk of medical liability for the healthcare 
providers. The complexity of the system with the potential of hardware or software 
failure is also a hurdle [30]. 
It is important that telemedicine must be implemented to the highest ethical standards to 
ensure that differences in physical and mental ability, age, gender and geographical 
location will not lead to marginalisation. Telemedicine must be regulated by 
unambiguous and exhaustive guidelines, applicable worldwide, in order to overcome 
the challenges for greater acceptability of telemedicine as a routine practice [30].  
2.3.5 Research Opportunities in Diabetes Telemedicine 
Recent advances in ICT have generated great interest in developing telemedicine care 
for diabetes management worldwide, even though the evidence of its benefits is limited. 
There is a strong suggestion that, with the current economic situation, governments are 
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looking to telemedicine to improve outcomes and lower costs. However, studies of 
telemedicine to date suffer from a combination of one or more design flaws: small 
sample size, poor design and user interface, or failure to demonstrate the long-term 
benefits. There are several reasons for fostering research in the area of diabetes 
management and future research in ICT for supporting diabetes management should 
ensure the acceptability of technology by the diabetic team [26,28,31].  
Due to small amount of published research on the economic benefits of telemedicine 
interventions for diabetes, it is difficult to influence medical policymakers who are 
currently reluctant to invest more in telemedicine. This type of information is needed 
before telemedicine will be able to find wide acceptability and support from all 
stakeholders. Thus it is important that more studies are conducted in order to make the 
telemedicine management of not only diabetes but other chronic diseases as well 
[25,31]. 
2.4 Literature Review of Telemedicine Systems for Diabetes 
Remote monitoring through telemedicine offers an efficient means of overcoming some 
of the limitations of the current system of monitoring and management of diabetic 
patients. This fact has stimulated research into the effectiveness of remote monitoring 
and the development of prototype systems for diabetes management. These 
developments were tailored to specific requirements. The limitations of the technologies 
used (such as cost, complexity and support) have restricted their deployment to a few 
niche locations. 
There is a significant body of published literature on the benefits of remote management 
of patients with diabetes mellitus. Early incarnations of such remote monitoring systems 
relied on the telephone as the underlying technology supporting communication. In 
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recent times however, new approaches that use the internet and smart phones for 
communications have been developed and this is a common feature of existing 
commercial ventures. 
Currently the diabetic team at Sheffield Children’s Hospital use Diasend telemedicine 
system [32] for management of type 1 diabetic patients. The advantage of this system is 
that diabetic nurse does not need to install the software provided by different meter 
companies. The hardware unit of Diasend, a small box, reads most of the current blood 
glucose meters and data is transmitted to the remote server which is running at the 
headquarters of Aidera AB, the manufactures of Diasend. The diabetic team have access 
to the patient’s data. The disadvantage of this system is that until the patient visits the 
clinic for the routine or emergency check-up, the diabetic team does not have access to 
the BGL of the patient. 
McMahon et al. [33] have evaluated a Web-based care management system for patients 
with poorly controlled diabetes. The aim of this system was to enhance diabetes patient 
education and to encourage patients’ self-empowerment and management abilities. This 
web based care management system seems to support these objectives. The strengths of 
the study are the careful design and the novel use of technology, together with 
education, remote health monitoring, and 2-way communication with a practitioner. 
This system has the ability to post professionally vetted material on secure websites, has 
24 hour accessibility, and is available to individuals in their homes regardless of the 
distance from their sites of healthcare. Patients with poorly controlled diabetes who 
adopt such a system and regularly exchange information with their healthcare providers 
are likely to derive important clinical benefits. With the increase in web connectivity 
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and worldwide deployment of internet connections, this infrastructure can support many 
current and emerging healthcare applications.  
However, the sample was mainly composed of all men with a mean age of 63 years and 
had above average level of education. The feasibility of implementation of such a 
system is restricted by the availability of computer equipment, software, internet access, 
training, and support. In addition, healthcare agencies may not have the staff required to 
mount this labour intensive approach. An advanced practice nurse made treatment 
recommendations, communicated with clinicians, and responded to patients within one 
working day. In addition, if patients did not log on to the website for two weeks, a 
coordinator prompted them to do so. Considering these feasibility challenges, the 
implementation of this system in clinical practice at present is unlikely.  
While investigating modem transmission of glucose values for an adolescent population 
with type 1 diabetes, Chase et al [34] concluded that fortnightly electronic transmission 
of blood glucose levels and other data in place of clinic visits is a possible alternative to 
clinic visits every 3 months. The glycaemic control and the incidence of acute diabetes-
related complications were comparable between the modem group and control group, 
even though the modem group did not have a 3-month clinic visit. The cost analysis of 
the study also revealed that using the modem for transmission of data was cost-effective 
in comparison to standard care. The other advantage of the modem group was that the 
children missed fewer days at school and parents missed fewer days at work as a result 
of omitting the 3-month visit. Care providers also benefitted in terms of saving the 
clinic space and the clinician’s time. The degree of patient satisfaction was reported to 
be similar in both groups. One important point determined by this study was that the 
clinicians found it hard to keep the patients motivated to communicate their blood 
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glucose levels to the clinicians in the standard care after a few years of the onset of 
disease.  
This study concluded that modem technology is suitable for use in an adolescent and 
young-adult population with type 1 diabetes and would be most appropriate for those 
who travel long distances to reach the clinic. However, a challenge for healthcare 
providers will be convincing health insurance companies to pay for implementation of 
this technology. 
 In order to improve diabetic care, Roudsani et al [35] evaluated a web-based diabetes 
management system called DiabNet. The system described an integrated portable 
glucometer, handheld computer, mobile phone and internet access in the diabetes 
management system. The salient features of this system are security steps which have 
been incorporated for the safety of the patient data and advanced graphics for patient 
data visualization by the diabetic team. DiabNet required the patient to input 
measurements into handheld computers which were connected to the DiabNet website 
through their mobile phones. The system has a client-agent-server architecture and tele-
consultation features. However, the use of the system may be restricted to the patients 
who have the computer skills and are highly motivated to look after their health. The 
drawbacks of this system are: 
 A handheld computer is required, hence extra luggage and high cost. 
 This system relies on manual data entry and hence is prone to data entry error.  
 A phone with an active internet connection is required which introduces extra 
costs of subscriptions to the telecom network data service. 
2-20 
 
In examining the security requirement for communication of patient records to remote 
management systems, Nigrin and Kohane [36] describe a prototype called Glucoweb, 
which is a system that allows patients with diabetes to transmit self-monitored blood 
glucose data from their glucometer device directly to their care provider over the 
internet. The key authentication and security measures to be addressed in the 
transmission of medical data to remote locations are highlighted in this study.  
Farmer et al [37] have described a mobile phone-based telemedicine system for 
management of  type 1 diabetes. This system was implemented on a Motorola T720i 
phone and a One Touch Ultra® blood glucose meter. The main advantage of the system 
is that it uses the existing mobile technology for transmission of data and feedback 
among the members of the diabetic team. However, this system uses a particular brand 
of mobile phone and glucose meter. It is very unlikely that all patients could have the 
same brand of the mobile device and glucometer. The other disadvantage of the system 
is that the patient must have access to the internet in order to transmit the data to the 
central server. 
Rudi et al [39] evaluated a telemedicine system which requires patients to enter the 
records of their glucose, insulin and food intake using a computer. The system has a rule 
based expert system based on Prolog to suggest to the patient or clinican the optimal 
amount of insulin intake required by the patient.   
Kim et al [40] presented a system which utilizes SMS for providing the feedback to the 
patients but glucose measurement data is still transmitted through an internet 
connection. 
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Despite of growing interest and research in telemedicine, not many studies have been 
reported for management of type 1 diabetes of children and young adults. Currently, the 
NHS in the UK still uses conventional care for diabetes management. Hence, more 
research is required to design a system which will be acceptable to all stakeholders of a 
diabetic team.    
2.5 Conclusions 
In this chapter, an overview and background of diabetes is presented and state-of-the-art 
technology in the area of telemedicine is discussed and analysed. Diabetes is a chronic 
disease and the number of people with diabetes is rising at an alarming rate worldwide. 
The people who suffer from diabetes are not receiving enough support to manage their 
diabetes due to the current system of management. Type 1 diabetes in particular is 
difficult to manage as the patient population suffering from the disease are generally 
children and young adults. One of the problems with the existing system of type 1 
diabetes management is the time delay in communication between the patient and 
healthcare providers. The patients see the diabetic team only after 3 months, which 
results in poorly managed diabetes. The results of poorly managed diabetes are 
catastrophic for the patient and incur massive costs to the NHS.  
Telemedicine is particularly well suited to manage diabetes as it requires interpretation 
and predetermined responses to many types of data that can be measured in the home by 
the patient. Recent advances in ICT can be exploited to develop the systems which are 
care driven to increase their acceptability among the various stakeholders of disease 
management. Further, as regulatory bodies become comfortable with legal and liability 
issues inherent to this approach to home care, then it is expected that the adoptability of 
telemedicine for monitoring and management of type1 diabetes will increase.  Hence 
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more studies are needed before telemedicine becomes a novel 21st-century tool for the 
monitoring and management of diabetes. During the analysis it was found that the 
existing telemedicine has been designed for highly motivated people and most systems 
need internet access for the patient to send the glucose reading to healthcare providers. 
Hence, the author of this thesis proposes a telemedicine system which has been 
designed and optimized specifically for management of type 1 diabetes in close 
coordination with Sheffield Children’s Hospital diabetic team.  
In the next chapter the architecture, design and implementation of the proposed system 
is explained. The chapter further explains the various levels of testing which are 
performed for validation and verification of the system. 
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 The Telemedicine System for Diabetes “WithCare+” Chapter 3
 
3.1 INTRODUCTION  
This chapter explains the architecture, design and development of “WithCare+” an 
innovative closed loop remote blood glucose monitoring system.   
The motivation for designing WithCare+ was to exploit recent technological advances 
in telecommunication and information technology [1,2] for the benefit of patients with 
chronic diseases in general. However, the scope of this work is to validate WithCare+ in 
the context of the remote monitoring of type 1 diabetic patients. The system has been 
evaluated in a field test, in collaboration with the Children’s Hospital, Sheffield and has 
been accepted by healthcare professionals of the hospital for a clinical trial. The clinical 
trial has started and will last for 18 months. 
In order to develop a telehealthcare solution which can improve the patients’ quality of 
life, it is important that engineering teams understand the requirements of both care-
providers and care-receivers. Even if an engineering team designs a telehealthcare 
solution with state-of-the-art technology, it is bound to fail if developed in isolation 
without taking into consideration the requirements of all stakeholders [3,4]. These ideas 
were given due consideration while designing the WithCare+ solution. A thorough 
requirement analysis was performed by taking into account inputs from all stakeholders. 
The interviews were conducted with different members of the diabetic team i.e. the 
clinicians, nurses, dieticians and patients.  
During the requirement gathering phase of the system, it was necessary for the author of 
this thesis to attend a couple of diabetic clinics to understand the current system of 
diabetic monitoring. Currently, the diabetic team at Sheffield Children’s Hospital use 
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“Diasend”, a commercial diabetes management system for glucose monitoring of 
patients [5]. However, there is no patient unit in Diasend and during a routine 
appointment the clinician uploads the glucose readings from the patient’s meter after 
plugging it to the Diasend hardware. The hardware sends the data to a remote server and 
the clinician is able to view the records of the patient. However, there is no facility for 
communication between patient and care provider on a daily basis. Based on this study 
and the literature review, a new system was envisaged which can address the problems 
faced by the members of the diabetic team. The analysis of the requirement gathering 
phase [6-8] established that WithCare+ has to accomplish the following specific 
objectives in order to be accepted by stakeholders of the diabetic team: 
 The WithCare+ system will need two main units: patient unit and server. 
 The WithCare+ client (Patient unit) will read the glucose readings from the 
glucometer via a universal asynchronous receiver/transmitter (UART) and 
transmit them to the patient’s phone in a specific format via Bluetooth. 
  The data received on the patient’s phone should be sent as an SMS on the GSM 
(Global System for Mobile Communications) /GPRS (General packet radio 
service) network to the GSM modem connected to the serial port of the 
WithCare+ server. The patient should receive a sent message confirmation on 
their mobile phone. 
 The SMS should be analysed at the server and rejected if it does not match an 
expected format, but any such event should be logged to a log file.  
 The SMS with correct format should be unpacked and the glucose readings 
should be saved into the database.  
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 A browser based web application should provide the healthcare providers with 
24/7 access to the patient data in a textual and graphical format. The user 
interface should match “Diasend”, a commercial telehealthcare solution which 
the diabetic team at Sheffield Children’s Hospital are currently operating, in 
order to cause minimum change to the system usability. 
 The user interface should be simple and the clinicians should be able to login to 
the system using a browser enabled device such as a desktop, laptop, tablet 
computer or smart phone. 
 The user interface should run on commonly used browsers such as Internet 
Explorer, Google Chrome and Mozilla Firefox. 
 With administrative rights the clinician should be able to add and edit the patient 
details.  
 The system should generate alerts in response to any undesired glucose levels 
such as hypoglycaemia or hyperglycaemia. The alarms generated should be 
visible to all members of the diabetic team on logging in to the system. 
 The system should also generate alerts if the glucose readings are not received 
by the server for a specific time which should be customizable as per the 
requirements of the patient. 
 The system should have the ability to send feedback to the patients using SMS 
or email.  
 To motivate patients to record their glucose measurement by improving the 
communication between all stakeholders of the diabetes team, the system should 
be integrated with social networking sites such as Facebook to improve the 
communication across the members of the diabetic team. 
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 The system should be integrated with Skype, which will reduce the cost of 
communication. 
 The system administrator should be able to diagnose any problems with the 
modem via the user interface. 
 A script should automatically run every day at 8 a.m. for system diagnostics and 
should be sent via email to the system administrator. 
If achieved, these objectives can encourage diabetic patients to monitor their blood 
glucose levels on a daily basis, which could in turn improve their HbA1C [9] and 
eventually reduce later-life complications. The system will be a friendly tool for the 
diabetic team to ease the pressure on their time and improve communication between all 
stakeholders of the team. Over time, these improvements could also reduce the cost of 
care for the National Health Service (NHS). However, the evaluation of the system for 
improving the HbA1C and reducing costs is beyond the scope of this study. The study 
about these benefits will be published by Dr. Neil Wright and his team (from Sheffield 
Children’s Hospital) after running the full trial. 
3.2 Architecture of WithCare+ 
Software architecture refers to high level abstraction of a software system that consists 
of high-level components and connectors, as opposed to implementation details. It gives 
an overview of how the system will behave and serves as the blueprint for low level 
design to produce a robust system. Performance, modifiability, and security of the 
system cannot be achieved without a unifying architectural vision. Design risks can be 
identified and mitigated during the initial design phase by an effective architecture 
[10,11]. 
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Figure 3.1 Architecture of  WithCare+ 
The proposed architecture of WithCare+ is illustrated in figure 3.1. As shown in the 
figure, the two major building blocks of the WithCare+ system are the patient unit and 
the server. The main aim of the patient unit is to transfer glucose readings from the 
glucometer to the server. However, the method of transferring the data to the server is 
flexible in this architecture, which is an innovative approach. In this work, two 
approaches of the data transfer have been tested.  
In the first approach, the patient unit is a wireless module, capable of reading glucose 
measurements from the glucometer via UART. The glucose readings can be transferred 
by the press of a button from the wireless module to a patient’s mobile phone via 
Bluetooth and further sent as an SMS via the GSM [12]. The SMS is received by the 
modem connected to the serial port of the WithCare+ server. The incoming SMSs are 
received on the SIM card of the phone and are read by the daemon process, which runs 
in the background. The daemon process continuously monitors the GSM modem for the 
incoming SMS and after the analysis of the SMS, it is logged into the database for 
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further processing. In future, this approach will be referred to as an SMS based-
approach. 
In the second approach, the patient unit uses an Ethernet connection [13] and sends the 
data to the webserver as a Hypertext transfer protocol (HTTP) message on a TCP/IP 
protocol [14-16], which after analysis is stored in the database for further processing. In 
future, this approach will be referred to as an ethernet-based approach. 
As is evident from figure 1, the WithCare+ server architecture is innovative in the sense 
that it can receive the data more than one way depending on the preference and 
circumstances of the patient. Both approaches have their pros and cons.  
The main advantage of an SMS approach is that the patient does not need an internet 
connection. The initial design was that the glucose data can be transferred from the 
patient unit to the mobile phone of the patient by exploiting the Bluetooth [17] serial 
port profile (SPP) of a patient’s phone. This approach worked with the low-end mobile 
phones which allowed communication over Bluetooth SPP. However, this design fails 
with smart phones, as Bluetooth SPP is not activated in these cell phones by the 
manufacturers, which was discovered after many hours of debugging time. This 
challenge was overcome by developing an application which established 
communication over the RFCOMM [18] protocol instead of SPP and successfully sent 
data as an SMS. This finding could save other researchers a lot of their debugging time. 
RFCOMM is a connection-oriented, streaming transport over Bluetooth and emulates 
serial ports. The section 3.3 will explain how in detail how this communication was 
achieved.  
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An SMS approach could be very useful for developing countries, where the internet is 
still not available in rural areas but mobile phones are.  In these areas, there is often no 
specialized diabetic healthcare centre and patients have to travel long distances to attend 
appointments in the main hospitals. This results in patients spending a full day 
travelling and in certain cases, patients may need to stay overnight to receive the advice 
from clinicians. In this case the patients also need to arrange for the overnight 
accommodation. An SMS-based approach can be very helpful for the patients in these 
areas as the glucose readings can be sent by the press of a button and devices can use 
the device with minimal training. The healthcare providers can advise the patients by an 
SMS.  However, at this stage the plan is to perform the pilot trial of the system for the 
type 1 diabetic population of Sheffield and in future WithCare+ could be evaluated in 
similar pilot trials in rural areas in different countries. 
The ethernet approach can be useful only if an internet connection is available to the 
patient. However, this is not always the case, which is a drawback. This approach has 
been tested and verified to prove that the WithCare+ server can receive the data either 
as an SMS or as an HTTP message. The ethernet-based approach will not be used in this 
pilot trial as the diabetic team at Sheffield Children’s Hospital prefer the SMS based-
approach due to its advantage that patients need neither a computer nor an internet 
connection. The work related to the ethernet-based approach has been presented at IEEE 
conference on embedded software and systems [19]. 
In order to handle messages from the SMS based approach, a GSM modem is connected 
to the serial port of the WithCare+ server machine. Text messages from the patient unit 
are received on the subscriber identity module (SIM) card of the modem and a daemon 
process continuously monitors the SIM card for the incoming SMS messages by 
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sending Hayes modem commands, known as AT commands, to the GSM modem. A list 
of AT commands is included in Appendix A. As soon as a new message is received, it is 
read by the process and analysed further. The daemon process either logs the message to 
the WithCare+ database if it matches a specific format or rejects the message if it does 
not match the format to ensure security. One more daemon thread reads the received 
SMS from the database and extracts the patient glucose readings with a timestamp. 
Then this extracted data is stored into the readings table of the database.  
The web application of WithCare+ is designed and developed using an n-tier web client 
architecture based on the model-view-controller design pattern. The Web-based user 
interface helps the health-care provider with data analysis, data visualization and 
decision support. It allows them to send feedback and therapeutic advice to patients 
from anywhere using the browser enabled device. The feedback can be sent via an SMS 
or email depending on the preference of the patient or caregiver and on the 
circumstances. WithCare+ is integrated with Skype and to other social networking sites 
in order to improve communication between stakeholders of the diabetic team, reduce 
costs and time of the communication. The idea to integrate the social networking sites 
was implemented in order to engage young adults. However, no clinical related data 
will be available on social networking sites in order to ensure the privacy of the 
patients. 
The end-to-end system provides information to the health-care provider, helping them 
make an informed decision for the management of the patient’s disease. All the relevant 
information about the patient including subjective data such as physiological and 
sociological data can be stored in the database. Health-care providers can view the data 
in tabular form or in the form of charts. It will alert the health-care providers when the 
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system detects the out-of-bounds glucose levels. The system can perform statistical 
analysis of the data, which can be useful in finding any correlation in the data. The 
system can provide a 24-hour open channel of communication between the various 
stakeholders of the diabetic team and can reduce some of their burden by letting them 
focus on problematic cases where more attention is required and the system can take 
care of routine communication.  
The proposed low-cost system, WithCare+, is expected to improve communication 
among the members of the diabetic team. This approach of using the existing 
communication channels and social networking sites for improvement of 
communication between patients and clinicians could lead more people to follow this 
strategy and could be useful to improve the clinical outcome. The work related to this 
approach has been presented at the Engineering in Medicine and Biology Society 
(EMBS), IEEE Conference [20]. 
3.2.1 Description of the Patient Unit 
The patient unit (electronic module) is connected to the glucometer and is operated by 
the patient. The module is physically small, requires minimal energy with lightweight 
packaging. The operation is intended to be almost transparent to the user with the 
minimum of configuration.  
There are four parts to the module, a Bluetooth IC (including host processor supporting 
a virtual machine for client applications), power supply, programmable serial interface 
and user interface. The user interface is a single button (to address issues of consent) 
and a tri-coloured LED. A switched mode power supply was designed around a low- 
power boost converter. The power supply unit at rest is disabled. The module is woken 
by pressing the button which enables the boost converter, and the Bluetooth IC then 
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asserts a hold-power signal which maintains the enable to the regulator until the module 
wishes to power off. The application software is written in embedded-C using the 
virtual machine (VM) and divided into a number of separate interacting sub-systems 
performing various required tasks. Message passing is used between the different 
threads. The operation of the applications functions are summarized in figure 3.2 and 
the module is shown in figure 3.3. A key requirement of the technology is minimal user 
interaction and therefore the front end was designed (based on firmware) to be 
compatible with most glucometers and most mobile phones including Android 
Smartphones. The device has been successfully tested with a range of mobile phones 
and glucometers (including the 5 most popular meters used by Sheffield Children’s 
Hospital patients). The device has received the required UK regulatory (MHRA) 
clearances to be used by the NHS patients in the clinical trials. The work related to 
development and testing of the patient unit was done by another Ph.D. student namely 
Anastasios Kanakis. 
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                              Figure 3.2 Summarized functions for Bluetooth applications 
 
  
Figure 3.3 WithCare+ Patient Unit 
3.3 Design of Bluetooth Communication using RFCOMM Protocol 
The aim of this work was to design and develop a proof of concept for establishing 
communication between an Android handset and a Bluetooth enabled device using 
Android’s Bluetooth application programming interface (API). Although the developed 
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software can run on any Android platform supporting the Bluetooth network stack and 
any Bluetooth enabled device, this concept has been tested on Android version 2.2.1 
(HTC wildfire mobile) and PSoC development Kit from Cypress Semiconductor 
Corporation [21].  
The APIs provided by the Android platform allows an application connecting to a 
Bluetooth enabled remote device. An Android application can use the Bluetooth APIs to 
perform the following actions: 
 Scan for other Bluetooth devices 
 Query the local Bluetooth adapter for paired Bluetooth devices 
 Establish RFCOMM channels 
 Connect to other devices through service discovery 
 Transfer data to and from other devices 
 Manage multiple connections 
The main steps involved for establishing communication and software module 
developed for the purpose are explained in the appendix D. 
3.4 Design of WithCare+  
In order to allow flexibility and accommodate changing requirements, the planning and 
design of the remote monitoring system was done using a combination of agile 
processes [22,23] and structured iterative development.  
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Figure 3.4 High Level Design of the WithCare+ Server 
The high level design of WithCare+ is illustrated in figure 3.4. The application layers of 
the system are shown and the interconnecting arrows indicate the data flow. The system 
is divided into the following components for development. 
3.5 Components of the WithCare+ Server 
The main components of WithCare+ server are: 
1. Incoming SMS monitoring and analysis  software module 
2. Web based interface for user interaction and maintenance 
3. Automatic scheduler 
3.5.1 SMS Monitoring and Analysis Software Module 
The patient unit module of WithCare+ reads glucose levels from the glucometer of the 
patient, packages them in a specific format as shown in Appendix B, and transmits data 
via Bluetooth to the patient’s phone. This data is then sent as an SMS to the Server, 
which is received by the modem connected to the Server. 
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Figure 3.5 Event Interactions of SMS Monitoring and Analysis 
Figure 3.5 shows the interaction of all the events in the SMS monitoring and analysis 
module. The two main components of the module are SMSHandler and EventHandler. 
These two server side components have been developed in Perl [24] and run as daemon 
processes on the Ubuntu Linux Server [25]. SMSHandler continuously polls the GSM 
modem for incoming messages by AT (Attention) commands [26]. This study uses a 
Wavecom modem but the commands are standard and applicable to all GSM modems. 
When a new SMS message arrives on the modem, SMSHandler reads the message and 
analyses its format with the expected format as shown in Appendix B. The message is 
inserted into the database events table and is also logged to a log file. If it does not 
match the format, the event is logged to the log file only and not stored in the database.  
The flow chart of SMSHandler is depicted in figure 3.6. 
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                Figure 3.6 Flow Chart of SMSHandler  
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Another important software module is EventHandler which acts as the central nervous 
system of the WithCare+ server software, reading the messages from the events table 
and analysing these messages based on the designed rules. Then, the glucose readings of 
the patient are extracted and then stored in the readings table of the database.  If there 
are any alarming conditions, such as low or high readings, the event handler generates 
an alarm in the event table. EventHandler also generates the alarm if the patient does not 
send the readings within the prescribed time, and it alerts the clinician. In addition, it 
keeps track of the health of the system using the automatic diagnostics software module, 
and raises an alert for the system administrator if any problem is detected with the 
modem. The system administrator can easily configure from the user interface how 
often the diagnostics should be run. This feature detects the problems early on and thus 
minimizes the chances of a system failure.  
3.5.2 WithCare+ Web Based User Interface 
The server software is designed using a model-view-controller design pattern, which is 
popular for designing robust systems [27, 28]. The main components of a web-based 
interface are: 
1. Data Access Tier 
2. Business Logic Tier 
3. User Interface 
3.5.2.1 Data Access Tier 
The data access tier is the code that executes select, insert and update queries directly on 
the database. This code has direct access to the database, and knows all the database 
details, i.e., the schema of tables, the name of fields, and the stored procedures. The data 
provider design pattern was used in the development of the data access tier to provide 
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the flexibility of using any other relational database management systems (RDBMS) 
that may have to be supported in future. 
The GlucoseReadingProviderBase and PatientProviderBase abstract classes implement 
the data provider pattern. These classes define Create, Read, Update and Delete 
(CRUD) methods and furthermore, include the implementation of helper methods for 
extracting data returned from the underlying database in an IDataReader object. The 
actual data access code is inside the secondary classes i.e. SqlGlucoseReadingProvider 
and SqlPatientProvider which inherit from the base class, and provide a concrete 
implementation for base class abstract methods. These are called providers, and are 
usually specific for one type of data store which in this implementation is MySQL [29]. 
The return types of provider class methods are entity objects or generic lists of entity 
objects. The provider classes also include a private helper method that extracts data 
from the data reader and creates the entity object for that table which is then returned to 
the business logic tier of the application. The methods of the provider classes follow a 
similar design pattern. 
At runtime, the DataProvider static class factory reads the configuration setting to 
identify the concrete data provider type to instantiate it. The new provider object is 
created, cast as the base provider type and returned to the caller. Data from the database 
is passed to the business logic layer by the entity classes PatientDetails, 
GlucoseReadingDetails and FeedbackDetails. An entity object has a default constructor 
and also a parameterized constructor that assigns parameter values to the properties of 
the class. All the entity objects follow a similar design pattern. Figure 3.7 shows the 
entity-relationship diagram of the WithCare+ database [30, 31]. 
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                           Figure 3.7 Entity relationship diagram  
 
3-19 
 
The entity-relationship diagram for the WithCare+ database was developed using 
MySQL Workbench 5.2. This diagram shows pictorial representation of physical tables 
in the database and relationship between the tables. In this database, the tables have one-
to-one or one-to-many relationship with each other. The patients table is the most 
important table of the database as it contains the subjective information of the patients. 
It has one-to-many relationship with the events table, which means more than one 
events will be associated with a patient. The events table stores messages received at the 
GSM modem for further analysis. The EventHandler reads the messages from the 
events table and stores the glucose reading values in the readings table after extracting 
them from the SMS. There is one-to-many relationship between the patients table and 
the readings table as one patient is associated to one or more readings. The clinician 
table has one-to-many relationship with the patient table as one or more patients are 
associated with one clinician. The smslog table stores the manual messages sent by the 
patients in response to the feedback from the clinicians and has many to one 
relationship to the patients table as many SMSs are associated to one patient. The limits 
table stores the high, low and average values of a patient and has one-to-one 
relationship with the patient table as each patient has only one or high value. The times 
table stores the times between which the patients have given their consent for receiving 
the feedback. If the clinician tries to send the feedback outside of these hours, the 
system waits till the preferred time of the patient and then sends the feedback. The times 
table has one-to-one relationship with the patients table as every patient has only one 
preferred timings. 
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3.5.2.2 Business Logic Tier 
Business logic tier is the middle tier of the application and contains the business rules, 
validation checks and functions for data manipulation. The code in the business logic 
layer takes the data retrieved by the data access layer and exposes it to the presentation 
layer client in a more abstracted and intuitive way, hiding low-level details such as the 
database schema and adding validation logic that ensures that the input is valid. The 
class diagram of the business logic layer is shown in figure 3.8. 
 
Figure 3.8 Business logic Tier classes 
The business logic layer has four business classes which inherit from the BllBase class. 
Each class has shared methods for common functionality and instance methods to 
provide functionality unique to each object. Each property of the class is mapped to a 
column in the database and the GetReading helper method converts an entity object 
from the data access tier to the corresponding business object. Other methods in the 
class perform select, insert, update and delete operations on the database using the 
appropriate methods of the data access tier.  
3.5.2.3 WithCare+ Web Interface 
The user interface is very important in any application because it is the only part of a 
system that the user interacts with. While designing the presentation tier the key 
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consideration was the requirements of the diabetic team, chief of which was simplicity. 
The WithCare+ web application was hosted on a Linux operating system running an 
Apache webserver. Screenshot of the user interface (UI) pages created in the web 
application are shown in the following diagrams.  
The web pages were developed using Hypertext Preprocessor (PHP) and PERL [32,33] 
and the layout of the pages was designed using a combination of XHTML mark-up, 
Cascading Style Sheet (CSS) and JavaScript. Only those features of JavaScript were 
used which are browser independent to make the application cross browser 
compatibility. The browsers used for testing are Internet Explorer, Mozilla Firefox and 
Google Chrome. The important pages of the WithCare+ UI are listed below: 
1. Patient Registration and modification page 
2. Inbox  
3. Event Registration 
4. Clinician Registration 
5. Event Logger Page 
6. Readings in tabular form and graphical form 
7. Feedback 
8. Admin for diagnostic purposes 
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Figure 3.9 Patient Registration Page 
Figure 3.9 shows the ‘patient registration page’ which allows a clinician to register a 
new patient, modify or view the details of an existing patient. The clinician can select 
this patient from the drop down box and the details of the selected patient are displayed. 
The rendering of the page was programmed to be context sensitive and in one mode it 
allowed existing patient records to be edited while the second mode enables clinicians 
to add a new patient record to the system. To ensure accurate data entry, existing fields 
are populated dynamically based on the existing records in the database. The page 
layout was improved by grouping the fields into sections so that the data input becomes 
more intuitive. Descriptive headers made it easier to distinguish the sections, for 
example the address section from the glucose limits section.  
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Figure 3.10 Inbox page gives an overview of Events 
Figure 3.10 shows the ‘inbox page’ of the WithCare+ user interface, which displays 
alerts generated by the system 3 cases. Firstly, glucose readings outside the set normal 
range are displayed in the inbox for the immediate attention of the diabetic team. 
Secondly, if a patient does not send the glucose readings for more than the specified 
period, an alert is generated in the inbox for the attention of the diabetic team so that the 
patient will be contacted immediately. Finally, the alerts are also generated by the self-
diagnostic software, which runs automatically every morning to check the health of the 
modem. In all these cases, the general format of the alert message is an event id (EID), 
date along with the time of the event, patient name and message about the event which 
caused the alert. EID acts as a hyperlink to the page where the action can be confirmed 
by the clinician as shown in figure 3.11. Similarly, the patient’s name acts as the 
hyperlink to the ‘feedback page’ as shown in figure 3.12.  A member of the diabetic 
team can contact the patient from this page by choosing one of the options for sending 
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the feedback i.e. text message, Email, Skype or Facebook. The feedback is sent using 
the patients preferred method.  
 
Figure 3.11 Inbox page gives an overview of Events 
 
Figure 3.12 Feedback to Patient  
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The inbox is one of the most important pages the clinician monitors on a daily basis for 
any alerts. In the case of an alert, the clinician sends the feedback to the patients and 
clears the alert from the ‘action-confirmed page’, which automatically deletes it from 
the database and also clears from the inbox. The other important page for the clinician is 
the ‘readings page’ as shown in figure 3.12. The clinician can select a patient from the 
drop down menu which shows the patient name and their NHS number to uniquely 
identify them. Also, healthcare professionals have options for selecting the time period 
by a radio button as shown in figure 3.13. Finally, the clinician can click the ‘view As’ 
button for viewing the data as a table, Day-Graph, Week-Graph or Time-Graph.   
 
Figure 3.13 Selection of viewing Reading 
If the clinician clicks on the table button, the glucose readings will be displayed in 
tabular form as shown in figure 3.14. The value of the glucose reading has been colour 
coded. Green indicates a normal value, red signals a high value and blue implies a low 
reading. The weekends in the table are coloured in red. This helps the diabetic team to 
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look at the problem cases quicky and send immediate feedback, as cases of 
hyperglycemia are more common during weekends.  
 
 
Figure 3.14 Readings in tabular form 
Figure 3.15 is a scatter plot of a typical day during the pilot trial. The x-axis of the 
graph shows the hours of day and the y-axis shows the glucose readings in mmol/dL. 
The range of the glucose level between the green lines (middle lines) is the optimal or 
desired level for a patient and the glucose reading value outside the red lines (top and 
bottom lines) indicates an abnormal BGL. The values above the top (red) line indicate a 
high level of glucose whereas the value below the bottom (red )line signals a low level 
of glucose. 
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Figure 3.15 Day graph of a patient with descriptive statistics  
Descriptive statistics such as minimum (min), maximum (max), median and mean 
values are calculated, which are helpful for the diabetic team when they choose to look 
at the data over a long duration e.g. three months which is generally the period after 
which HbA1C is repeated. The graph also shows the trend line or regression line of the 
glucose levels. 
The layout of the pages shown above was designed to improve usability and 
productivity. System testing and validation, as explained in the next section, were 
performed to ensure the web interface is functional and operates in line with the 
requirements. 
3.5.3 Automatic Scheduler 
This software has been developed to run certain jobs automatically, which is very 
helpful for system diagnostics.  The jobs can be scheduled to run every minute or every 
day at a specific time or every week. Currently, the modem self-diagnostic test is run 
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every morning to check the health of the modem and the report is automatically sent to 
the system administrator. This utility software is also used to back up the log files.  
3.6 Testing and Validation 
In order to test the system, a helper program was written to generate test data to 
populate the tables in the database. With the database loaded with test data the 
application was run and extensive manual testing was performed.  
Application testing was performed using advanced testing and debugging tools. The 
main test procedures carried out during the testing process were: 
 Integration tests to ensure that that the assembled system operated according to 
the design. 
 Functionality tests out to ensure that the system functions according to the 
specification. 
 Regression tests after any changes in the software, to ensure that existing 
functionality was not affected by new changes. 
 Performance tests to ensure that the codes were executed optimally with 
minimum overheads.  
MySQL Workbench 5.2 was used to analyse the stored procedures and the WithCare+ 
database was tuned and optimised to ensure a high performance. Subsequent 
performance tests were carried out which showed a significant improvement in query 
execution times. Finally, verification was done to ensure that the final system met all 
the design objectives and operation was in line with the functional specification. The 
tests performed focussed on functionality and security in the deployment environment. 
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3.6.1 Usability Testing 
The usability testing [34,35] of WithCare+ was performed in two stages. Five people 
volunteered to use the patient unit and performed the glucose tests with a calibration 
solution. One of the volunteers acted as a doctor who registered the other volunteers as 
patients. The volunteers used their personal phones for transmitting the data to the 
server and performed the glucose tests 3 times a day. The volunteers were able to use 
the system with minimal training. This testing was undertaken by the volunteers for one 
week and the feedback received was positive.  
In the second stage of usability testing, the patient units were handed over to the 
diabetic team at the Children’s Hospital, Sheffield. The diabetic team at the hospital 
performed the usability testing for two weeks. During this phase of testing, some 
members of the diabetic team acted as patients. The phones used by the members of the 
diabetic team were Blackberry and Android phones as most of the patient population 
have these two types of phones. After this testing period, it was agreed by the project 
management to start the clinical trial of the system in a phased manner, which will be 
explained in the next section. 
3.7 The Clinical Trial 
In the first phase of a pilot trial, 6 patients were registered by the Children’s Hospital, 
Sheffield. All the patients have smart phones with 4 patients having Android phones 
and 2 patients having Blackberry phones. All of these patients were given training to 
use the WithCare+ patient unit. The two steps which are involved in setting up the 
WithCare+ device is the pairing between phone and the device for establishing 
Bluetooth communication. This step has to be performed only once by the clinician at 
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the time of the patient registration. The training manual for this step can be found in 
Appendix C.  
The next step to be performed by the patient is to send the glucose readings to the 
server. This step is very simple, patients will perform the glucose readings as usual, but 
they need to connect the WithCare+ device to their glucometer and ensure their mobile 
phone is within the Bluetooth range to establish communication with the WithCare+ 
device. The glucose readings can be sent to the server on the press of a button. The 
training manual can be found in Appendix C. 
3.7.1 Problems Faced During the Pilot Trial 
One of the six patients who owned a Blackberry had many applications running on it 
and as a result, application although installed successfully did not function properly. 
One of the installed applications was blocking the Bluetooth communication between 
the phone and the device. This problem was resolved by resetting the phone (with 
consent of the patient) to the factory setting thereby deleting all the existing applications 
and reinstalling the applications. This work around seems to work well as the last resort 
in the problematic cases. However, this approach will not work if the patient does not 
agree to reset his phone to factory settings. This has been classed as known issue for the 
application. 
One more patient who attended the training and was able to send data initially did not 
continue from the next day.  Even though the diabetic team tried to contact her, there 
was no response. This is the typical case of non-compliance from the patient and will be 
quite common in practical situation. One of the reasons for integrating social media 
with WithCare+ was to engage these types of patients. However, the NHS at the 
3-31 
 
moment does not allow running Facebook or Skype as a policy matter. An application 
has been filed by the diabetic team to their information technology department to seek 
permission for running Facebook and Skype within the context of WithCare+. Once this 
permission is granted it may be possible to understand the impact of social media sites 
to engage the unmotivated patients. 
One other patient stopped sending readings after one week. After analysing it was found 
that patient did not know that his phone had run out of credit. It was suggested that £10 
voucher may be provided to overcome this kind of problem for the patient population 
without a contract phone. The contract phones generally provide unlimited free SMS. 
The other three patients who started well, one patient sent readings after each 
measurement. The other two preferred to sent all three measurement at the end of the 
day. After two weeks, however, no readings were being received by the Server. On 
investigation, it was found that the resistor of the cable, which connects glucometer to 
the WithCare+ patient unit, was not able to withstand the rough use of the patients. To 
solve this problem, this resistor was replaced by a more robust surface mount device 
(SMD) type resistor in all the patient units. The pilot will run for 18 months and clinical 
outcomes, cost analysis will be published by the diabetic team.   
3.8 Conclusions 
The aim of this research was to design and develop a 24/7 telemedicine system for 
remote monitoring of type 1 diabetic patients, which will improve the communication 
between the patients and members of the diabetic team and give to healthcare 
professionals the ability to look at the glucose readings on a daily basis using any 
browser-enabled system. A number of challenges were faced during the design, 
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development and testing of the system in order to ensure acceptability of the system by 
all stakeholders. 
The first major design challenge was to ensure possibility of widespread deployment in 
areas where internet access is limited and this was overcome by relying on the SMS 
messaging through components developed to support SMS communication. There is no 
telemedicine system, to our knowledge, which does not need patient internet connection 
for sending the glucose readings, which is a bottleneck for most of the systems. One 
distinct advantage of WithCare+ patient unit is that is does not need an internet 
connection as it operates on the GSM network. 
The second major design challenge was that of scalability, performance and security, 
which is addressed by adopting model-view-controller (MVC) architecture. The third 
design challenge was to provide a web standard compliant, user friendly browser based 
interface to the application for use by healthcare providers in managing their patients 
and this was achieved by designing an aesthetically pleasing layout without using any 
web application framework to keep the interface simple and easily manageable. The 
fourth design challenge was to develop a system which will be low cost and this 
objective was fulfilled by using freely available open-source software. 
Withcare+ has been accepted by Sheffield Children’s Hospital for a clinical trial, which 
will run for 18 months. The system developed is recommended for all deployment 
scenarios and will be especially useful in rural areas of developing countries where 
mobile phone usage is common but internet access is limited. 
Remote monitoring with continuous feedback from the diabetic team could motivate 
patients to take glucose measurements 3 to 4 times a day as needed. However, this 
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‘invasive’ procedure for glucose level monitoring on a daily basis for many years is 
clearly inconvenient and contributes to many patients not doing enough blood tests 
which in turn results in less control of the blood glucose level. This can lead to 
hypoglycaemia, hyperglycaemia or later life health complications. To address this issue 
researchers have tried to come up with non-invasive techniques for glucose 
measurement. The next chapter explains basic theory of non-invasive glucose 
measurement and the preliminary work done in this area. 
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 Non-invasive Glucose Measurement Chapter 4
 
4.1 Introduction 
As discussed in chapter 3, WithCare+ with continuous feedback from the diabetic team 
could motivate patients to do glucose level measurements 3 to 4 times a day as needed.  
However, there remains a problem with the current method of glucose measurement. 
The finger prick method for glucose level monitoring on a daily basis for many years is 
clearly inconvenient and results in many patients not doing enough blood tests, which in 
turn results in less control of the blood glucose level. This can lead to hypoglycaemia, 
hyperglycaemia or later life health complications. The difficulties involved with 
invasive measurement can clearly be addressed by a non-invasive method. In order to 
make non-invasive glucose measurement a reality, different types of spectroscopic and 
optical methods, such as near-infrared (NIR) spectroscopy, Raman spectroscopy, 
fluorescence spectroscopy and polarization have been extensively researched [1-5]. NIR 
spectroscopy has become an established technology due to its non-invasive, non-
destructive, and painless nature. In addition, it requires little or no sample preparation 
and provides a reasonable signal to noise ratio [6-8]. 
However, ascertaining the concentration of glucose from NIR spectra in the presence of 
other signals, associated spectral variations and the underlying spectral noise remain an 
issue. This challenge can be handled by employing sophisticated multivariate data-
analysis algorithms to build robust regression models for the calibration and prediction 
of glucose concentration from NIR spectra. Principal Component Regression (PCR), 
and Partial Least Squares Regression (PLSR) are popular methods traditionally utilized 
in the data-analysis of NIR spectra [9-13], but to date these techniques  have not been 
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able to address the calibration challenges associated with non-invasive glucose 
measurement.  
In this chapter, locally weighted partial least squares regression (LW-PLSR) is proposed 
for the determination of glucose concentration from NIR data. LW-PLSR is developed 
by combining the locally weighted regression (LWR) technique with PLSR. The 
efficacy of the proposed model is validated in the determination of concentration of 
glucose from samples of an aqueous solution composed of glucose, urea and triacetin in 
different concentrations. The experiments were carried out in a non-controlled 
environment or sample conditions. 
The next section gives an overview of NIR spectroscopy, Section 4.3 gives an overview 
of pre-processing techniques, Section 4.4 explains the theory of multivariate calibration 
techniques and Section 4.5 describes experimental work carried out for collecting the 
spectral data. Section 4.6 explains the development of the proposed novel calibration 
model and Section 4.7 concludes the chapter. 
4.2 NIR Spectroscopy 
Spectroscopic techniques are used to determine the concentration of a substance by 
measuring how it interacts with light. Absorbance is a logarithmic ratio of the radiation 
falling upon a material, to the radiation transmitted through a material. When the 
amount of absorption is plotted against wavelength, the resulting curve is referred as a 
spectrum. Each material shows a specific and reasonably unique spectrum, depending 
on its chemical structure, physical state, and temperature. 
NIR spectroscopy utilizes the near infrared region of the electromagnetic spectrum         
(2.5-0.78 μm). This type of spectroscopy is based on molecular overtone and 
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combination vibrations. The NIR spectrum of glucose possesses three absorbance bands 
in the combination (2-2.5μm) and the overtone (1.54-1.82μm) regions of the NIR 
spectrum centered at 2.115, 2.273, 2.326 μm and at 1.73, 1.69 and 1.61 μm respectively. 
The absorbtion of glucose in the short-wave region (0.7-1.33μm) is low. Most recent 
glucose analysis studies used the combination region where absorbtion of water is low 
and the glucose absorbance band is narrower (particularly at 2.273 μm) [14]. 
Near infrared (NIR) has become popular due to its advantages such as: 
 It is capable of providing non-destructive analysis i.e. the samples can still be 
used after analysis. 
  NIR spectroscopy is painless. 
  It requires little or no sample preparation for analysis of sample. 
  NIR spectroscopy is faster in comparison to other techniques with a reasonable 
signal-to-noise-ratio (SNR).  
 The cost per sample is often much lower as compared to other analytical 
methods. 
NIR spectroscopy received a big boost with the advent of the Fourier transform infrared 
(FTIR) spectrometer in the early 1970s. The FTIR spectrometer provides high SNR, 
short scanning time, high resolution, high precision and improved data processing as 
compared to conventional infrared systems [15]. The instrument obtains infra-red 
spectra by collecting the interferogram of a sample signal using a Michelson 
interferometer. 
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4.2.1 NIR for Non-invasive Glucose Measurement 
 
NIR spectroscopy is based on collecting reflectance or absorption spectra of the tissue 
with a spectrometer. When a spot on the skin is illuminated with near-infrared light, the 
light is partially absorbed and scattered due to its interaction with chemical components 
in the illuminated tissue. The rest of the light which is either transmitted or reflected out 
of the tissue is received by optical detectors. An analysis of changes in the intensity of 
the light combined with multivariate calibration techniques [29] allows the extraction of 
the tissue’s chemical components, including glucose. 
Glucose produces one of the weakest NIR absorption signals per concentration unit of 
the body’s major components. NIR spectroscopy measurement enables investigation of 
tissue depths in the range of 1 to 100 millimeters with a general decrease in penetration 
depth as the wavelength value is increased. NIR transmission through a finger web, ear 
lobe, and finger cuticle or reflected from the skin of the forearm has been attempted and 
NIR diffuse reflectance measurements performed on the finger cuticle have shown good 
correlation with blood glucose [30]. 
NIR transmission spectroscopy with multivariate calibration method was used by 
Robinson [31] to measure blood/tissue glucose concentrations in diabetic subjects. 
Burmeister and Arnold [32], employed near-infrared transmission spectroscopy to study 
non-invasive blood glucose sensing in different measurement sites like nasal septum, 
lip, cheek, and tongue. The results demonstrated that the tongue provides spectra with 
the highest signal-to-noise ratio as it contains the least amount of fat. The transmission 
spectra of the tongue in the 1400 -2000 nm range was collected and results  showed a 
standard error of prediction (SEP) in excess of 54 mg/dl for all diabetic subjects [33].  
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Hiese and Marbach [34] have studied determination of glucose concentration through a 
diffuse reflectance measurement in the oral mucosa membrane in the spectral range of 
1111 - 1835 nm and reported the best SEP value of 43 mg/dl. 
 Jagemann et al. [30] used a fibre optic probe to study diffuse reflectance over the 800 - 
1350 nm range on the middle finger of the right hand. The blood glucose concentrations 
of the test persons were perturbed using carbohydrate loading. The results were 
evaluated using PLSR and radial basis function neural networks. In these tests, the mean 
root square prediction error was 3.6 mg/dl. This method has the advantage that no 
reagents are required for the measurements and that fibre optical components can be 
used. As a consequence only insulators are in direct contact with the skin. Furthermore 
the spectrometer can be constructed without moving parts, leading to a rugged design. 
Diffuse reflectance studies of the inner lip also have shown good correlation with blood 
glucose and indicated a time lag of 10 minutes between blood glucose and the 
measurement signal [35].  
In spite of all these studies in the area of non-invasive glucose measurement no 
successful device has been translated into clinic. A device of reasonable size, acceptable 
accuracy and at reasonable cost would be an instant medical and commercial success.  
However, the NIR spectra of glucose in many samples in practice are weak in intensity, 
broad and overlapped. Furthermore, the quality of the collected spectra is influenced by 
several factors such as: 
1. The high background spectra of water. 
2. Baseline variations resulting from the instrumental and ambient variations. 
3. High frequency noise, such as the detector noise. 
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4. Highly overlapping of the spectra of other components because the structure of the 
glucose molecules and bonds are similar to many other constituents of samples.  
5. The light scattering which is anisotropic, inhomogeneous, and nonlinear resulting 
from the surfaces and other constituents in a sample. The scattering reduces the SNR 
due to the degradation of the optical signal. 
6. The low concentration of glucose in the blood serum as compared to other 
constituents. 
 NIR spectroscopy has attracted interest from healthcare [16], pharmaceuticals [17] and 
the food industry [18], although it is acknowledged that certain issues such as 
specificity and calibration still remain a challenge. 
These challenges, which arise in quantitative analysis of glucose using NIR, can be 
overcome by using multivariate calibration methods coupled with pre-processing 
techniques. The ability of the multivariate model to forecast the concentration of the 
analyte of interest in the measurements is susceptible to the quality of the collected 
spectra. The practical data, even though collected from an instrument of high signal-to- 
noise ratio, is affected by negative factors such as baseline variations, noise, and 
scattering. The quality of the raw spectra is thus improved by using pre-processing 
methods before developing the multivariate model. The next section gives an overview 
of pre-processing techniques. 
4.3 Pre-processing Techniques  
The goal of pre-processing is to prevent unwanted variations from influencing the 
prediction capability of the multivariate model by removing the high frequency noise 
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and baseline variations, enhancing the resolution of the collected spectra, removing the 
high background, selecting the appropriate spectral range, and compensating for the 
negative influence of temperature variation. Derivatives and digital bandpass filtering 
are some of the techniques which are commonly employed in pre-processing of NIR 
spectra.  
4.3.1   Derivatives 
Derivatives of spectra have been known and used in NIR spectroscopy for a long time.  
NIR spectra often suffer from baseline shift, background noise, light scattering and 
multi-collinearity among variables, depending on the type of sample and 
instrument. The elimination of these unwanted variations is important for the 
development of a robust and accurate calibration model.  It is possible to minimize the 
impact of these unwanted variations by applying suitable signal processing (pre-
processing) methods. One of the common mathematical pre-processing methods used in 
chemometrics is taking derivatives to improve spectral resolution. The first derivative 
can eliminate baseline offset variations within spectra. However, the signal-to-noise 
ratio (SNR) deteriorates due to derivatives as they increase the noise. The higher the 
degree of differentiation used, the higher is the decrease in SNR. This problem is 
resolved by smoothing the data before differentiation and using a low degree of 
differentiation. The common  smoothing and differentiation method  in chemometrics is 
the one used by Savitzky and Golay [19] , which is based on a moving window 
averaging method. 
The simple difference method, the Moving Window Polynomial Least Squares Fitting 
(MWPLSF) or the frequency domain techniques may be used for obtaining derivatives 
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of the spectrum. The first derivative of a discrete absorbance spectrum in a simple 
difference method can be expressed as:  
ii
ii
i
aa
a
 

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

1
1
                                                                                                               
where 
ia  is the first derivative of the spectrum, ia  is the absorbance spectrum at the 
wavelength i , i=1…m and m is the number of variables (wavelengths). For equal 
differences between the sampling wavelengths, the first derivative can be simplified as 
follows: 
 
Despite its simplicity, the simple difference method has the main drawback that the 
peaks, maximum or minimum, are shifted relative to the raw spectra. This method is 
suitable for spectra with high resolution.  
 The MWPLSF method is based on the Savitzky-Golay smoothing filter. In this method, 
the n-th derivative is obtained by performing the smoothing operation against the n-th 
ordinary derivative of the polynomial, instead of using the polynomial directly as in the 
smoothing. Once the weighting coefficients are obtained, they are used to obtain the 
differentiated spectra. The MWPLSF method will not introduce shifting in the peaks of 
the differentiated spectra but will set the two sides of the differentiated spectrum to 
zero.  
The most practical method used to compute the derivative of the spectra is that using the 
Fourier transform. Compared to the MWPLSF method, the Fourier differentiator is 
iii aaa  1
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simple, direct, fast and does not require complex tables. Furthermore, it does not 
produce a shifting in the peaks or suppress part of the spectrum ends.  For example, the 
first derivative can be computed by multiplying the Fourier transform of the spectrum 
by a linear ramp. Then the inverse Fourier transform of the multiplier output is 
computed to produce the differentiated spectrum in the wavelength domain.  
4.4 Multivariate Calibration Methods  
 Multivariate regression algorithms are widely used in quantitative analysis of 
NIR spectra to extract the concentration of the analyte of interest from the collected raw 
spectra of the samples[20]. This goal is achieved by generating a calibration model that 
is related to the response and predictor variables, which can be used later on to estimate 
the response to new data. The model development involves two phases: 
 1. Calibration phase 
 2. Validation phase 
Spectral data are divided randomly into the training dataset and test dataset. In the 
calibration phase, a training dataset is used to generate the calibration model, and a test 
dataset is used to test the generalization capability of a calibration model to predict the 
concentration.  
Generally, the performance of the calibration model can be evaluated by computing the 
coefficient of determination (R
2
), the root means square error of calibration (RMSEC), 
the root mean square error of cross validation (RMSECV) and the root mean square 
error of prediction (RMSEP).  
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R
2
 is a measure of how well the regression line fits the data. This statistic determines the 
amount of variation in the data that is adequately modelled by the calibration equation 
as a fraction of the total variation. In other words, it denotes the strength of the linear 
association between dependent values and independent values. The value of R
2
 
represents the percent of the data that is the closest to the line of best fit. This means if 
the regression line passes through every point on the scatter plot, then all of the 
variation in dependent variable is explained by the independent variable and R
2
 will be 
equal to 1. Conversely, if the regression line is away from the points on the scatter plot, 
the value of R
2 
will decrease. So R
2  
values approaching 1.0 are attempted when 
developing calibration models. R
2
 is calculated as below: 
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where ic  is the actual concentration of the training data, i
cˆ is the predicted 
concentration of the training data, c  is the mean concentration and np is the number of  
samples. 
The RMSEC describes the degree of agreement between the calibration model 
estimated concentration values for the calibration samples and the accepted true values 
for the calibration samples used to obtain the model parameters in Equation (2). 
Typically, RMSEC provides overly optimistic estimates of a calibration model’s 
predictive ability for samples measured in the future. This is because a portion of the 
noise in the standards is inadvertently modeled by the estimated parameters. A better 
estimate of the calibration model’s predictive ability may be obtained by cross- 
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validation with the calibration samples or from a separate set of validation samples. 
RMSEC is calculated as below: 
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where ic  is the actual concentration of the training data, icˆ is the predicted 
concentration of the training data, and pn is the number of training samples.  
The RMSEP measures the ability of the calibration model to predict the concentration 
of the analyte of interest for new data. The RMSEP is computed as below:                                                                  
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where it  is the actual concentration of the test data, is itˆ  is the predicted concentration 
of the test data, and n is the number of test samples.  
Cross-validation is a statistical technique of estimating and comparing calibration 
models by dividing data into two segments: one used to train a model and other used to 
test the model. In cross-validation the training and test sets must cross-over in 
successive rounds so that each data point has a chance of being validated against. K-fold 
cross validation is the basic form of cross-validation while the other forms are special 
cases of k-fold. 
In k-fold cross-validation the dataset is first partitioned into k equally sized data 
segments. Then k iterations of training and testing are performed such that different fold 
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of data is used for testing while the remaining k-1 folds are used for training. The main 
advantage of k-fold cross validation is the accurate performance estimation of the 
calibration model. The flow chart below depicts the process of k-fold cross validation. 
In chemometrics, data mining and machine learning 10-fold cross-validation (k=10) is 
the most common. 
   
 
 
 
 
 
 
 
  
Figure 4.1 Flow Chart of K-Fold Cross Validation 
Other common method of cross-validation is leave-one-out cross-validation (LOOCV), 
which is a special case of k-fold cross-validation. In LOOCV all the data except for a 
single observation are used for training and the model is tested on the left out 
observation. This process of leaving a sample out is repeated until all the calibration 
Break down n data samples 
into k sets of size n/k. 
Train the model on k -1 
datasets and test it on 1 left 
out set 
Calculate predicted and 
actual responses 
( =residual) 
Use the model to predict the 
response(s) of the test 
samples 
Repeat the process k times 
until each set is used for 
testing  
4-13 
 
samples are left out. LOOCV provides unbiased estimate but its variance can lead to 
unreliable estimates.   
4.4.1 Multiple linear Regression (MLR) 
A multiple linear regression (MLR) analysis is carried out to predict the values of a 
dependent variable given a set of explanatory variables. In spectroscopy, MLR is used 
to model the relation between the concentration and the absorbance spectra based on the 
inverse Beer-Lambert law [28] as:  
Concentration= Bias + (Regression coefficient 1) * (Absorbance at Wavelength 1) + 
(Regression coefficient 2) * (Absorbance at Wavelength 2) + 
+…+ (Regression coefficient N) * (Absorbance at Wavelength N) 
This can be written as: 
C =    +        …..+                                           (4) 
where C is the estimated concentration of the analyte of interest,    is known as the 
regression coefficients vector,     is the absorbance at each considered wavelength. 
The regression coefficients    are computed based on the Least Squares method 
[21,22]. 
CAAA TTN
1)(                                                                                                  (5) 
MLR is one of the oldest methods used in multivariate analysis but has some 
drawbacks. The main problem with MLR is that the number of samples should be 
greater than or equal to the wavenumbers. However, in practice it is common to 
measure the NIR spectra with a number of wavenumbers greater than the number of 
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samples. Furthermore, increasing the number of samples may produce collinearity and 
nonlinearity, which cause the MLR calibration model to be unstable since it does not 
work well with collinearity and nonlinearity. To overcome these problems, principal 
component regression (PCR) has been developed based on principal component 
analysis (PCA) and MLR. 
4.4.2 Principal Component Analysis (PCA) 
PCA is a mathematical technique which was proposed by Pearson [23] and Hotelling 
[24], whilst the best modern reference is from Joliffe [21,22]. This technique takes 
advantage of an orthogonal linear transformation to convert a set of correlated 
independent variables into uncorrelated variables known as principal components. In 
this transformation, the first principal component accounts for most of the variance in 
the data and each successive component has the highest variance as compared to the 
other principal components with the constraint of being orthogonal to the preceding 
components.  Thus, PCA transforms the data to a new coordinate system such that the 
first principal component lies on the first coordinate and the second principal 
component lies on the second coordinate and so on. Usually only the first few principal 
components are used and the final components are ignored as they are assumed to 
model noise. This is how the PCA reduces the dimensionality of the multivariate data 
without losing useful information, and this reduction in dimensionality helps to find the 
patterns in the multivariate data, which are otherwise hard to find in high dimensions.  
In PCA, the original data matrix X, consisting of n spectra (rows) containing p 
datapoints, is described by the scores S matrix and loadings L matrix as shown in eq (6). 
The matrices S and L can be calculated by the nonlinear iterative partial least squares 
(NIPALS) algorithm [21,22]. The matrix E consists of the difference between the values 
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in the data matrix and the values obtained from the multiplication of S and L
T
. It is 
called a residual matrix (or error matrix). Each datapoint is described by eq (7). 
                                                                                                                          (6)     
    = ∑       
 
                                                                                                          (7) 
where i is the sample number and j is the spectral wavelength. 
4.4.3 Principal Component Regression (PCR) 
PCR is one of the most popular regression techniques for the development of calibration 
models for NIR data.  It is a regression analysis technique which utilizes principal 
component analysis (PCA) when estimating regression coefficients. 
It is implemented in two steps. In the first step the scores of the data matrix are 
computed using PCA; then the scores are regressed against the concentration of the 
analyte of interest to generate the MLR calibration model instead of the original 
absorbance spectra.  
 The first step of principal component analysis (also referred as eigen analysis) can be 
performed by singular value decomposition (SVD) on the data matrix X. This operation 
decomposes X into three matrices which are termed as the left singular values (LSV) 
matrix (or the U matrix); the singular values matrix; and the right singular values matrix 
(RSV) (or the V matrix), which is referred to as the P matrix in PCA terminology. It is 
now easy to find the scores matrix and the Loadings matrix from these decomposed 
matrices.  
The scores matrix is calculated as: 
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S= X * V where S is the scores matrix, X the data matrix and V the loadings matrix. 
The S and V can be used to calculate X as below: 
X (estimated) = S * V
T               
(8) 
If c represents the concentration matrix, then the set of regression coefficients is 
calculated as below: 
      b= V *  S
-1
 * U
T
  * c                                                                                                (9) 
The predicted or estimated values of c are computed as  
c (estimated) = (S * V
T
) * b                                                                                          (10) 
The PCR calibration model can be realized regardless of the selected wavelengths, and 
it is reliable against collinearity. The PCR model is robust and stable against noise if the 
number of observations is high, since it can eliminate loading factors that have low 
variance and low influence on the change of the absorbance spectra. On the other hand, 
PCR has some limitations that may degrade the performance of the calibration model. 
For instance, sometimes the analyte of interest only provides a small contribution to the 
variation of the spectra A and the information related to it may be eliminated during the 
decomposition process, especially if the signal to noise ratio of the measured spectra is 
low. Hence, the quality of the PCR model is sensitive to the number of loading factors 
that are used to generate the calibration model. Secondly, the PCR algorithm 
decomposes the absorbance spectra matrix A only, without using prior information 
about the analyte concentrations. Thirdly, in the presence of outlier data the principal 
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components may not represent the maximum variation of the information correctly 
because the covariance matrix is sensitive to outlier data [21,22]. 
4.4.4 Partial Least Squares Regression (PLSR) 
Partial Least Squares Regression (PLSR) has become the most widely used technique 
for quantitative analysis of NIR spectra as it overcomes most of the serious drawbacks 
of other multivariate techniques. It decomposes the concentration and the absorbance 
spectra simultaneously, and uses prior information about concentrations in the 
decomposition of the spectra, and vice versa.  
Compared to PCR regression, PLSR is more robust, faster, and requires a lower number 
of factors to establish the calibration model [21,22]. In contrast to PCR, the PLSR 
model extracts and sorts the loading factors according to their covariance with the 
scores of the absorbance matrix and the concentration vector. Thus, information related 
to the concentration of analyte of interest will be enhanced even if it has a low 
contribution in the absorbance spectra, because the chosen factors weight the spectra 
according to their correlation with the concentration.   
PLSR utilizes a special case of singular value decomposition (SVD) which uses both the 
data matrix and concentration vector and decomposes them to their scores and loading 
matrices. This special case of SVD is sometimes referred as PLSSVD to distinguish it 
from SVD which is used in the case of PCR as discussed in previous section. 
If X represents a data matrix, c is the concentration vector and the PLSSVD operation is 
performed on these matrices, the result is three matrices. These matrices are known as 
the left singular values (LSV) matrix (or the U matrix); the singular values matrix; and 
the right singular values matrix (or the V matrix). These decomposed matrices make it 
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easy to find the Scores matrix and Loadings matrix. The Loadings matrix is simply the 
V matrix; this matrix is referred to as P matrix in PLS terminology.  The PLS Scores 
matrix is calculated as: 
S = X * V where S is PLS Scores matrix, X is the data matrix and V is the PLS loadings 
matrix. Now S and V matrices can be used to calculate the following: 
X (estimated) = S * V
T
   (11) 
The set of regression coefficients is calculated as follows: 
    b= V * S
-1
 * U
T
 * c   (12) 
The predicted or estimated values of c are computed as below: 
      c (estimated) = (S * V
T
  ) * b     (13) 
The PLS model can extract a number of factors; however, the first few factors have 
information about the analyte of interest while the last factors may be the result of 
noise. Furthermore, increasing the number of factors may produce overfitting, which 
may lead to degradation of the performance of the calibration model. Therefore, the 
factors that have information about the analyte of interest should be determined to 
prevent overfitting and allow a high capability of prediction.  
4.4.5 Locally Weighted Regression (LWR) 
Linear models are sometimes limited due to the chemical properties of a measuring 
object, which have an intricate effect on NIR spectra. Another issue in building robust 
models is how to manage the variations in the process characteristics, which is vital in 
the chemical industry. Thus, maintenance of the models is an important issue to 
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consider in soft-sensors [9]. Traditional linear models generally discard the data after 
the training phase, losing potentially valuable extra information during the prediction 
phase. This is why “memory-based” methods, such as locally weighted regression 
(LWR), retain the training data and use it for each prediction, has been advocated for 
dynamic processes. LWR is a technique for non-parametric regression, which performs 
regression around a point of interest, using only training data that are “local” to that 
point [25].  
In LWR, the goal is to fit    to minimize ∑              
2
 where    is the i-th row of 
the input data matrix,    is the output vector, and the  s are non-negative valued 
weights. For a particular value of i, if    is large then   is chosen in such a way as to 
make           small. However, the           error term will be ignored in the fit if  
    is small. 
The weights depend on the particular point     Moreover, if |     | is large, then    is 
small and if |     | is small then    is close to 1. Thus, the value of   is selected in 
such a way as to give a higher “weight” to the errors in training examples close to the 
query point x.   is called the bandwidth parameter and it controls how quickly the 
weight of a training example falls off with the distance of its     from the query point  . 
The following equation can generalize appropriate choice of weights for a vector   and 
bandwidth parameter  : 
      [ 
      
       
   
]                (14) 
LWR has been  used in  agriculture and the food industry [18]. Kim et al have used 
LWR for estimation of active pharmaceutical ingredients[26]. However, as far as can be 
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determined, no attempt has been made to date to use LWR for predicting glucose 
concentrations from NIR spectra.  
 In this work, a local linear regression model using LW-PLSR is developed for the 
quantitative analysis of glucose using NIR spectra, for the first time. It is also shown, 
using practical data in a non-controlled environment, the proposed LW-PLSR technique 
performs better than the conventional linear regression techniques. 
4.5 Experimental Work 
In this study, samples were prepared by mixing glucose, urea and triacetin in a 
phosphate buffer solution. Urea and triacetin are used to model the urea and 
triglycerides in blood, respectively. Thirty samples were prepared with different 
concentrations in each sample ranging from 20 mg/dL to 500 mg/dL for glucose, 0 to 50 
mg/dL for urea, and 10 to 190 mg/dL for triacetin to reflect their concentrations in 
blood. The buffer solution was prepared by dissolving 3.4023 g of potassium di-
hydrogen phosphate and 3.0495 g of sodium mono-hydrogen phosphate in distilled 
water. 5-Fluorouracil was added as a preservative. The aqueous solutions of glucose and 
urea were prepared by dissolving dry solutes in the buffer solution, whereas, triacetin 
solution was prepared by diluting it with the buffer solution.  
A Fourier transform spectrometer (FTIR Cary 5000 version 1.09) was used for 
collecting the spectrum from the samples, in the wavelength region of 2100nm to 
2400nm with a spectral resolution of 1 nm.  
The samples were placed on an infrared quartz cuvette with a fixed pathlength of 1mm. 
The spectrum of each sample was collected 3 times without removing the sample from 
the spectrometer and in this manner a total of 90 spectra were collected. The absorbance 
spectrum of a buffer solution was used as the reference.  
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Many previous studies have been carried out in a controlled environment to compensate 
for the effect of baseline variations. However, in this study the experiments were carried 
out in a non-controlled environment in order to validate the ability of the proposed 
models, to deal with the uncompensated variations, and determine the concentration of 
glucose from the NIR spectra of the mixture solutions.  
4.6 Model Development, Results and Discussion 
The collected spectra, spanning the whole range of concentrations, were divided 
randomly into two datasets. The training dataset consisted of 60 spectra and test dataset 
consisted of 30 spectra. The training dataset was used for the calibration and the test 
dataset for validation of the models respectively. 
4.6.1 First Derivative as a Pre-processing Technique 
 PCR, PLSR, and LW-PLSR were initially developed without pre-processing. All the 
models were developed following the same basic procedure. The models were built by 
utilizing Matlab version R2010a. 
The “10-fold” cross validation [27] was performed to find the optimal number of 
principal components (PCs) and latent variables (LVs) in case of PCR and PLSR 
respectively. In the cases of PCR and PLSR, most of the variance is explained by 6 
factors as illustrated in figure 4.2 and figure 4.3 respectively. 
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Figure 4.2 Variation Captured in the PCR Model 
                      
 
Figure 4.3 Variation Captured in the PLSR Model 
The motivation for using the locally weighted regression was to compare the ability of 
LWR-PLSR to predict the concentration of glucose in the mixture solution of glucose, 
triacetin and urea in comparison to PCR and PLSR. 
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 Figure  4.4 Scores Plot of the PCR Model 
Figure 4.4 above shows the scores plot generated using PCR. As shown in the plot,    
is 0.88, RMSEC is 47.69 mg/dL, RMSECV is 51.07 mg/dL and RMSEP is 49.4 mg/dL.. 
Next, a calibration model was developed using the PLSR. The scores plot generated 
using PLSR is shown in figure 4.5 where     , RMSEC, RMSECV and RMSEP were 
improved to 0.97, 22.54 mg/dL, 31.59 mg/dL and 27.56 mg/dL, respectively. However, 
as can be seen the RMSEP is still high.  
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Figure 4.5 Scores Plot of PLSR Model 
 
 
                          Figure 4.6 Glucose Prediction Performance using the LW- PLSR 
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Then, a predictive model was developed utilizing the LW-PLSR technique. As shown in 
figure 4.6,    , RMSEC, RMSECV and RMSEP have improved to 0.98, 11.32 mg/dL, 
25.79 mg/dL and 23.85 mg/dL respectively. 
Table 4.1 below summarises the comparative results of the three calibration models 
developed. The data was pre-processed using the first derivative in all these models. As 
is evident from the table, LW-PLSR performed better in comparison to PCR and PLSR.  
Table 4.1 comparison between PCR, PLSR and LW-PLSR  
 
 
   
 
RMSEC 
(mg/dL) 
 
RMSECV 
(mg/dL) 
 
RMSEP 
(mg/dL) 
    
Optimal 
Parameters 
 
Pre-processing 
PCR 0.93 47.69 67.59 35.29 6PCs None 
PCR 0.88 21.18 51.07 49.40 6PCs First Derivative 
PLSR 0.94 10 34.07 32.81 6LVs None 
PLSR 0.97 22.54 31.59 27.56 6LVs First Derivative 
LW-
PLSR 
0.95 15.15 30.17 28.35 6LVs None 
LW-
PLSR 
0.98 11.32 25.79 23.85 6LVs First Derivative 
 
4.7 Conclusions 
In this chapter, LW-PLS has been investigated and validated for the quantitative 
analysis of glucose using NIR spectroscopy. The proposed novel model has been 
developed and applied to predict the glucose concentration in a mixture composed of 
triacetin, urea and glucose in a non-controlled environment.  
The predicted results of the proposed model have been compared with models 
developed using PCR and PLSR on the same data under the same pre-processing 
conditions. The proposed model has been shown to yield improved performance in 
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terms of     , RMSEC, RMSECV and RMSEP. This improvement in prediction is 
encouraging and may lead to the possibility of more specialists in the area of 
chemometrics using the LW-PLSR.  
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 Support Vector Regression as a Calibration Technique  Chapter 5
 
5.1 Introduction 
As seen in chapter 4, when ascertaining the concentration of glucose in the presence of 
other signals from spectra of their mixtures, associated spectral variations and the 
underlying spectral noise remain an issue, which can be overcome by implementing 
sophisticated multivariate data-analysis algorithms to build robust regression models for 
calibration and prediction of glucose concentration from NIR spectra. Principal 
Component Regression (PCR), and Partial Least Squares Regression (PLSR) are 
popular methods traditionally utilized in the data-analysis of NIR spectra [1-4], but 
these techniques may not be the best choice with non-linear data. Non-linearity in NIR 
spectra may arise from various factors, namely: deviations from the Beer- Lambert law, 
which are typical of highly absorbing samples; non-linear detector responses; 
interactions between analytes, etc. 
Multilayer perceptron-based neural network models have been reported [5-7] with 
relative success due to their strong non-linear modelling capabilities. The drawback of 
neural networks is the existence of more than one local minimum. Recently, support 
vector machines (SVM) [8-11] have demonstrated promising results similar to those of 
the neural-networks for non-linear data but without its pitfalls. SVM, a supervised 
learning algorithm, was initially developed to build the classification models and was 
later extended to build the regression models. SVM, when used to build the regression 
models, is known as Support vector regression (SVR). It has recently attracted growing 
research interest in chemometrics due to its good generalization ability, unique and 
global optimal solution [8-11]. 
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Information about an NIR spectrum is present in the frequency components of its 
Fourier transformation which reside in the mid-band range, while the noise and baseline 
variations reside in the high and the low frequency range of the Fourier domain 
respectively. The quality of the raw spectra can potentially be improved by using an 
optimized digital bandpass (DBP) filter to enhance performance of the calibration 
model. In recent research, a time domain filtering technique has been used as a pre-
processing technique on input data while building the PLS regression model [12].  
The digital band pass filter was effective in filtering out the low frequency baseline 
variations and high frequency noise [13]. In particular, Chebyshev and Gaussian filters 
have been reported [17] to improve the results of PCR model for determination of 
glucose concentration but no attempt has been made to couple these filters with support 
vector regression. In this chapter, a novel model that couples SVR with a DBP filter is 
presented. The performance of the model is investigated using both time domain 
(Chebyshev) and frequency domain (Gaussian) filters for the quantitative analysis of 
glucose from NIR spectra. The model is validated using experimental data collected 
from the Fourier transform near-infrared (FT-NIR) spectrometer.  
The next section gives an overview of digital bandpass filtering, Section 5.3 explains 
the theory of SVR and Section 5.4 describes experimental work carried out for 
collecting the spectral data. Section 5.5 explains the development of proposed novel 
calibration models and Section 5.6 concludes the chapter. 
5.2 Support Vector Machines Theory 
SVM is firmly grounded in the framework of statistical learning theory which was 
developed by Vapnik from 1960-1990 [9,10]  and the research was further extended by 
Smola and his co-workers to its current form [11] . In SVM the model represents a 
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training sample set as vector mapped space so that the samples from the different 
classes are separated by a distinct gap which is as large as possible. The model is then 
validated on a test set for prediction accuracy. SVMs demonstrate high performance in 
practical applications when solving complex classification problems [9,10]. The SVMs 
were initially developed as a binary classification tool and  were extended to solve 
regression problems [11] . 
Support vector machines (SVM) are based on the structural risk minimization (SRM) 
principle, which is superior to the traditional empirical risk minimization (ERM) 
principle [9-11] . SRM seeks to minimize an upper bound of the generalization error; on 
the other hand, ERM only minimizes the training error. Thus, SRM usually achieves a 
higher generalization performance than ERM based neural networks in solving many 
machine learning problems. In SVM, the solution to the problem is only dependent on 
support vectors, which are a subset of the training data points. SVM is a predictive 
classification and regression tool, which uses machine learning theory to maximize the 
accuracy of prediction and automatically avoids over fitting of data. In this study, 
however, the aim is to use SVM for regression (SVR). 
The commonly used variations of SVR are epsilon-SVR and nu-SVR [10]. The 
important parameters for building the SVR model are gamma, cost, and epsilon or nu.  
Given a training dataset  (xi, yi) (where yi   R, xi   R
n 
, and i=1  , Where m is the 
number of training samples) x is the vector of predictors and y is the vector of 
responses. SVR approximates the predictive function f  as follows [11]: 
f (x)=ω⋅ ϕ(x) + b                     (1) 
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where ω is the weight vector in primal weight space; (.) denotes the dot product; ϕ(x) 
represents the high-dimensional feature space which is nonlinearly mapped from the 
input space xi and b is the bias term. The coefficients ω and b are estimated by 
minimizing the regularized risk function. 
The optimization problem can be expressed as: 
 
 
         
 
 
∑   
 
            )              (2)  
The        is referred as the regularized term and minimizing        will ensure the 
function is as smooth as possible, thus acting as the function capacity controller. The  
term             )  is the empirical error measured by the ɛ-insensitive loss function, as  
defined below : 
           ) ={
                                  
                              
                     (3) 
The equation (3) defines  - tube [12] and if the predicted value is within the tube the 
loss is zero, while if the predicted point is outside the tube, the loss is the magnitude of 
the difference between the predicted value and the radius ɛ of the tube. C is called the 
regularization constant. 
To obtain  ω and b, Eq. (2) is transformed to the primal objective function (4) by 
introducing the positive slack variables       
  as below: 
 Minimize 
 
 
         
 
 
∑       
  
   )                                    (4) 
Subject to                               and                      
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In most cases the optimization problem (4) can be solved more easily in its dual 
formulation  
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)                                           (5) 
In the equation above, L is the Lagrangian and      
       
  are Lagrange multipliers. 
Hence, the dual variables in (5) have to satisfy positive constraints, 
  
     
                                           (6) 
It follows from the saddle point condition that the partial derivatives of L with respect to 
the primal variables are as defined in equations (7), (8), (9) and (10). 
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Substituting (7), (8), (9) and (10) in (5) yields the dual optimization problem as shown 
in equation (11). 
Maximize W (     
 ) 
=∑         
    ∑        
  
 
    
 
     
 
 
∑       
  
 
     
       
              (11) 
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Subject to ∑       
      =0 and      
  [   ] 
In the derivation of equation (11),   ,  
 
 
 are eliminated through equation (10) which 
can be  rewritten as     
       
 . 
Equation (7) can be written as   ∑        
       
 
     and thus  
      ∑       
  
 
   
                          (12) 
This is known as support vector machines regression expansion, i.e.   can be 
completely described as a linear combination of training patterns xi . As is clear from 
equation (12), the complete algorthim can be described in terms of the dot products 
between the data.   
The parameter b can be calculated by exploiting the Karush–Kuhn–Tucker (KKT) 
conditions, which state that at optimal solution the product between dual variables and 
constraints has to vanish. In SVR this means: 
{
  [              ]   
  
 [    
           ]   
                                            (13)  
{
               
  
   
       
    
   
                  (14) 
From the equation (13) it follows that only for              the Lagrange 
multipliers may be nonzero. So one gets a sparse expansion of  , and samples that 
come with non-vanishing coefficients are called Support Vectors (SVs). From equation 
(13) and (14), b can be computed as : 
   
                               
                  
         
                                                                      (15)                 
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The inner product can be defined through a kernel function K(x,xi) according to 
Mercer’s condition. So the equation (12) can be rewritten as follows: 
     ∑       
                                                     (16)  
By applying kernels, all necessary computations can be performed directly in input 
space, without mapping to feature space ϕ(x). Some of the popular kernel functions are  
(1) Linear kernel: K(xi,xj) =          
(2) Polynomial kernel: K(xi,xj) = (        + p)
d
 , p > 0, d   N 
(3) Multilayer Perceptron Kernel: 
 K(xi,xj) = tanh (           ),   > 0,   > 0 
(4)  Gaussian radial-basis function (RBF) kernel  
K(xi,xj) = exp(−||xi−xj|| 
2 
 /  ),  where    is a  kernel parameter.  
Using different kernel functions, it is possible to construct different learning machines 
with arbitrary types of decision surfaces. 
First, based on the above theoretical statement of SVR, it is possible to estimate the 
regression using a set of linear functions that are defined in a high-dimensional feature 
space, while the inputs have non-linear performance. Second, SVR carries out the 
regression estimation by risk minimization, based on statistical learning theory, where 
the risk is measured using Vapnik’s  -insensitive loss function [11]. Finally, SVR 
implements the SRM principle, which minimizes the risk function consisting of the 
empirical error and the value of the confidence level. 
5.3 Experimental Work 
This section describes how the same collected spectra as discussed in chapter 4 were 
used to generate the DBPF-SVR, DBPF-PLSR and DBPF-PCR calibration models. In 
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this study, samples were prepared by mixing glucose, urea and triacetin in a phosphate 
buffer solution. Thirty samples were prepared with different concentrations in each 
sample ranging from 20 mg/dL to 500 mg/dL for glucose, 0 to 50 mg/dL for urea, and 
10 to 190 mg/dL for triacetin to reflect their concentrations in blood.  
A Fourier transform spectrometer (FTIR Cary 5000 version 1.09) was used for 
collecting the spectrum from the samples, in the wavelength region of 2100nm to 
2400nm with a spectral resolution of 1 nm. The spectra for each sample were collected 
3 times without removing the sample from the spectrometer and in this way a total of 90 
spectra were collected. The absorbance spectra of a buffer solution were collected at the 
beginning of the experiments and used as the reference. The experiments were carried 
out in a non-controlled environment in order to validate the ability of the proposed 
model to determine the concentration of glucose from the mixture solutions. 
5.4 Model Development, Results and Discussion 
The collected spectra, spanning through the whole range of concentration, were divided 
randomly into two datasets. The training dataset consisted of 60 spectra from 20 
samples and the test dataset consisted of 30 spectra from remaining 10 samples. The 
training dataset was used for the calibration and the test dataset for validation of the 
models respectively. 
5.4.1 First Derivative as a Pre-processing Technique 
 PCR, PLSR and SVR were initially developed without pre-processing. All the models 
were developed following the same basic procedure. The models were built by utilizing 
Matlab version R2010a and LIBSVM [14], a library for support vector machines. 
The “10-fold” cross validation was performed to find the optimal number of PCs and 
LVs in case of PCR and PLSR respectively as explained in chapter 4 section 4.6.1.  
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In the case of SVR, the choice of the kernel function is a key step. The radial basis 
function (RBF) kernel nonlinearly maps samples onto a higher dimensional space, and 
unlike the linear kernel, it can handle cases when the relation between class labels and 
attributes are non-linear. Furthermore, the linear kernel is a special case of RBF as 
reported by Keerthi and Lin [15].  The sigmoid kernel behaves similarly to RBF in 
certain cases [16] . The RBF kernel has fewer parameters than the polynomial kernel 
which reduces the model complexity. Hence, the RBF kernel exhibits fewer numerical 
difficulties in contrast to polynomial kernels whose values may go to infinity or zero.  
In this study, the RBF was used as the kernel function because of its compactness as 
compared to other feasible kernel functions for developing the SVR model. In addition 
to  , there are two other important parameters when using RBF kernels: the cost 
parameter C and epsilon ɛ. Kernel parameter   controls the shape of the separating 
hyperplane and C represents the penalty associated with errors larger than epsilon.  
Increasing γ usually increases the number of support vectors. According to Eq. (4), the 
parameter C determines the trade-off between the model complexity and the degree to 
which deviations larger than ɛ are tolerated in the optimization formulation (4). In 
addition, referring to Eq. (11), C decides the range of values 0≤        
   ≤ C, i=1,...,m,  
assumed by dual variables used as linear coefficients in the SVR solution. Hence, a 
‘good’ value for C can be chosen equal to the range of output values of the training data. 
However, the selection of parameter C also depends on the domain of application 
knowledge. In training the regression function, there is no penalty associated with 
points which are predicted within distance ɛ  from the actual value. Decreasing ɛ  forces 
closer fitting to the training data. In order to prevent the over-fitting problem, the cross-
validation approach is exploited to find the optimal parameters. In K-fold cross-
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validation, the training set is divided into K-subsets of equal size. Sequentially, one 
subset is tested using the regressor trained on the remaining (K − 1) subsets.  
 
                 Figure 5.1 Scores Plot of SVR Model 
The predictive performance of the models was evaluated by the following standards: 
correlation coefficient (R
2
), root mean square error of calibration (RMSEC), root mean 
square error of cross validation (RMSECV) and root mean square error of prediction 
(RMSEP). A good model should have a high correlation coefficient, low RMSEC, low 
RMSECV, and low RMSEP. 
Table 5.1 below summarises the comparative results of the three calibration models 
developed. The data was pre-processed using the first derivative and digital band pass 
filters in all these models. As is evident from the table, SVR coupled with digital band 
pass filters performed better in comparison to PCR and PLSR.  
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5.4.2 Digital Bandpass (DBP) Filtering as a Pre-processing Technique 
The purpose of evaluating SVM for regression coupled with digital band pass filter was 
to compare its ability to predict the concentration of glucose in the mixture solution of 
glucose, triacetin and urea with the SVR pre-processed with derivatives. The results 
were further compared with the traditional linear methods such as PCR and PLSR 
coupled with DBP filters. Figure 5.2, 5.3 and 5.4 show the flow charts of selecting 
optimized parameters when coupling PCR, PLSR and SVR with DBP filter 
respectively.   
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   DBPF  (Gaussian or Chebyshev) 
                       (c,w) 
     No 
If (SEP <= 
SEP_OPT) 
                       PCR model 
 
             c_opt=c , w_opt=w 
            SEP_opt=SEP 
       
C_opt, w_opt, SEP_opt 
If c>=c(max) 
Increment w by 0.001 
 
     No 
yes 
     No 
yes 
      
              Parameter Initialization 
c=0.01 f, w=0.001 f, cmax=0.5 f, 
wmax=0.8 f, SEP_opt=200, PCs=6   
 
If w>=w(max) 
yes 
Increment c by 0.001 
 
Figure 5.2 Flow chart of Parameter optimization for DBP using 
PCR Model 
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   DBPF  (Gaussian or Chebyshev) 
                       (c,w) 
     No 
If (SEP <= 
SEP_OPT) 
                       PLS Model 
 
             c_opt=c , w_opt=w 
            SEP_opt=SEP 
       
C_opt, w_opt, SEP_opt 
If c>=c(max) 
Increment w by 0.001 
 
     No 
yes 
     No 
yes 
      
 
              Parameter Initialization 
c=0.01 f, w=0.001 f, cmax=0.5 f, 
wmax=0.8 f, SEP_opt=200, LVs=6   
 
If w>=w(max) 
yes 
Increment c by 0.001 
Figure 5.3 Flow chart of Parameter optimization for DBP using 
PLS Model 
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15 
 
If  C>= Cmax 
 
yes 
Increment w by 0.001 
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initialize w 
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If   >=  max 
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                   , 
initialize C,   
Increment C by 0.25 
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yes 
yes 
yes 
yes 
     No 
     No 
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     No 
Increment           , initialize 
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yes 
Figure 5.4 Flow chart of Parameter optimization for DBPF-SVR 
Model 
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.  
          Figure 5.5 Comparison of the PCR, PLSR and SVR models using Gaussian Band Pass filter (BPF) 
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Figure 5.6 Comparison of PCR, PLSR and SVR models using the CBP filter 
Figure 5.5 and Figure 5.6 show the comparison of PCR, PLSR and SVR models using 
the Gaussian and Chebyshev digital band pass filters for pre-processing respectively. 
The plots show measured glucose concentration on the x-axis and the y-axis represents 
the predicted glucose concentration for three different models.  
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Table 5.1 Comparison of SVR with PCR and PLSR  
    RMSEC
(mg/dL) 
RMSECV 
(mg/dL) 
RMSEP
(mg/dL) 
Optimal Parameters Pre-processing 
PCR 0.88 21.18 67.59 49.40 6PCs None 
PCR 0.93 47.69 51.07 35.29 6PCs First Derivative 
PCR 0.96 17.54 56.7 24.77 6PCs GDBPF** 
PCR 0.98 15.93 51.23 18.98 6PCs CDBPF*** 
PLSR 0.94 10 34.07 32.81 6LVs None 
PLSR 0.97 22.54 31.59 27.56 6LVs First Derivative 
PLSR 0.96 12 38.3 24.59 6LVs GDBPF** 
PLSR 0.98 15.92 28.43 19.06 6LVs CDBPF*** 
SVR 0.90 12.5 38.44 42 
 
C=0.1*10^6
None 
SVR 0.98 13.5 28.98 22.98 
 
C=0.2*10^6
First Derivative 
SVR 0.98 12.09 28.00 15.17  C=0.04*10^6 GDBPF** 
SVR 0.98 12.47 27.40 14.59  C=4.5*10^6 CDBPF*** 
GDBPF**= Gaussian digital band pass filter CDBPF*** = Chebyshev  digital band pass filter 
5.5 Discussion  
NIR spectra often suffer from baseline shift, background noise, light scattering and 
multi-collinearity among variables, depending on the type of sample and 
instrument. The elimination of these unwanted variations is important for the 
development of a robust and accurate calibration model.  It is possible to minimize the 
impact of these unwanted variations by applying suitable signal processing (pre-
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processing) methods. One of the common mathematical pre-processing methods used in 
chemometrics is taking derivatives to improve spectral resolution. The first derivative 
can eliminate baseline offset variations within spectra. In this work Savitzky and Golay 
[19] , which is based on a moving window averaging method, was employed for 
differentiation. As shown in table 1, employing the first derivative improves prediction 
capability of filter. However, the signal-to-noise ratio (SNR) deteriorates due to 
derivatives as they increase the noise. The higher the degree of differentiation used, the 
greater is the decrease in SNR.  
Hence, in this work DBPF has been employed to compare their results with the first 
derivatives. Due to its simplicity, the DBP filtering has generated a great interest in 
different applications of signal processing. DBP filter, in context of NIR spectroscopy, 
is a set of mathematical techniques for improving the accuracy and reliability of raw 
spectra by filtering out undesired signals. This filter can be controlled and fine-tuned to 
obtain maximum information about the analyte of interest. It can be defined completely 
by its centre frequency and bandwidth. The DBP filter can be implemented either in the 
frequency or time domain. In time-domain filtering, the modified profile of raw spectra 
is acquired by convolving the raw spectra with the impulse response function of the 
desired filter. In frequency-domain filtering, fast Fourier transformation (FFT) of the 
raw spectra is computed, and the result of this transformation is then multiplied by the 
frequency response function of the digital filter. Finally, an inverse fast Fourier 
transform (IFFT) is computed on the result of the previous step to get the filtered 
spectra [13].  
Chebyshev filters exhibit an optimal trade-off between a steeper roll off and passband 
ripple as compared to other time-domain filters. The filter is defined by its transfer 
5-19 
 
function and filtering operations are performed in the time domain. The order of the 
filter, magnitude and location of the ripple control the characteristics of the filter. 
Gaussian filters are designed to give no overshoot to a step function input while 
minimizing the rise and fall time. A Gaussian filter can be implemented either in the 
time domain or frequency domain. The Gaussian function has the same profile in the 
time domain and frequency domain and it can be represented completely by its standard 
deviation and mean, which are identical to band width and centre frequency respectively 
[13]. Hence, in this work the Gaussian filter has been implemented in the frequency 
domain. 
In the optimization process, the DBP filters were designed by varying the centre 
frequency(c) from 0.01f to 0.5 f and the bandwidth (w) from 0.001 f to 0.8 f with an 
interval of 0.001 f, where c and w are normalized between 0 and 1. In each iteration, the 
designed DBP filter is coupled to the calibration model and the RMSEP value is 
calculated.  The calibration model with the minimum RMSEP value corresponds to the 
optimized DBP filter. The optimum parameters for the Gaussian filter were c=0.019 f, 
w=0.012 f and for the Chebyshev filter were c=0.03 f, w=0.10 f, where f is the 
normalized frequency between 0 and 1, c is the central frequency and w is the 
bandwidth of the filter.  
5.6 Conclusions 
In this chapter, DBPF-SVR have been investigated and advocated for the quantitative 
analysis of glucose using NIR spectroscopy. The novel model has been developed and 
applied to predict the glucose concentration in a mixture composed of triacetin, urea and 
glucose in a non-controlled environment. The prediction results of the proposed models 
have been compared with models developed using DBPF-PCR and DBPF-PLSR on the 
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same data under the same pre-processing conditions. The proposed model has been 
shown to yield improved performance in terms of     , RMSEC, RMSECV and 
RMSEP. 
This improvement in prediction is encouraging and may lead to the possibility of more 
specialists in the area of chemometrics using DBPF-SVR  
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 Conclusions and Future Work Chapter 6
 
This chapter presents a summary of the work carried out for this dissertation and 
recommends future work for this research topic. 
6.1 Summary and Conclusion------------------------------------------------------------------6-2 
6.2 Future Work---------------------------------------------------------------------------------6-3 
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6.1 Summary and Conclusion 
The research work presented in this thesis has focussed on developing a telemedicine 
system which can facilitate different stakeholders in a diabetic team. The members of a 
diabetic team are the patient, the parents or caregivers, the clinician, nurses and the 
dietician. The primary focus of WithCare+ is to improve the communication between 
different members of a type 1 diabetic team. The proposed system has been validated 
and accepted by healthcare professionals at the Children’s Hospital, Sheffield. The 
clinical trial, which started in March 2013, will run for 18 months.  
 Even though healthcare providers can engage patients by providing continuous 
feedback with the help of WithCare+, invasive glucose measurement still remains a 
challenge, as it is demotivating for the patients to measure their blood glucose levels on 
a daily basis. This difficulty can be addressed by non-invasive glucose measurement. 
NIR spectroscopy is one of the most promising techniques that has been identified for 
non-invasive glucose measurement due to its non-destructive, non-invasive and painless 
nature. However, the clinical translation of the technology still remains a challenge due 
to the calibration of instruments for the determination of glucose concentration from the 
NIR spectra of blood serum or plasma. This research presents two novel calibration 
techniques which were developed by exploiting existing signal processing techniques 
and machine learning algorithms. The research has demonstrated that these techniques 
can successfully determine and predict the concentration of glucose from the NIR 
spectra of mixtures composed from glucose, triacetin and urea in a phosphate buffer 
solution. The concentration of components is selected to be within their physiological 
range in the blood.  The experiments were carried out in a non-controlled environment 
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to show that the proposed calibration models can effectively suppress most of the 
experimental variation. 
6.2 Future Work 
Future directions of this work could focus on the following issues: 
The performance of WithCare+ has been validated by healthcare professionals at 
Sheffield Children’s Hospital and the system has passed the user acceptance test (UAT). 
The system is currently being validated in a clinical trial in a phased manner for 18 
months. In future, the system will be validated by running a main trial with more 
patients for longer duration.  
The system could also be extended to monitor other related parameters of type 1 
diabetic patients such as insulin and calorie intake. This would enable healthcare 
professionals to advise patients on the optimum amount of insulin intake through an 
SMS based on the inputs calculated by a learning algorithm. This learning algorithm 
could be fine-tuned by the healthcare professional’s knowledge and experience, which 
could result in an expert system. This can be further extended to the concept of the 
artificial pancreas using the principles of a closed loop control system. 
The design of the server software and the database of WithCare+ is flexible enough to 
monitor other chronic diseases. The future work could enhance the WithCare+ patient 
unit so that the data from other physiological parameters can also be transmitted using a 
GSM network and the WithCare+ server software and database can be easily extended 
to support these extra physiological parameters. 
For non-invasive WithCare+, the proposed calibration techniques for non-invasive 
glucose measurement in this study are validated in mixtures composed of three 
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components in aqueous solutions. In the future work, however, the proposed methods 
can be validated through more experiments using blood plasma or blood serum and a 
large number of samples. 
Currently, each research group performs different experiments under different 
conditions. Therefore, it is recommended that a database of the datasets should be built 
for all research groups involved in non-invasive glucose measurement. Such a database 
would enable researchers to compare proposed calibration models using the same 
reference data without reinventing the wheel.     
 
 
Appendix A List of Commonly used AT Commands 
   AT Commands     Meaning     
  AT+CGMI     Get the name of manufacturer    
  AT+GMI     Get the ID of manufacturer     
  AT+GMM     Get the Model information     
 AT+CGMR     Get software version     
  AT+CPAS     Get mobile phone activity status  
 AT+CREG     Get mobile network registration status
  AT+CSQ     Get radio signal strength     
 AT+CMGS     Send SMS messages     
  AT+CMGR     Read SMS messages     
  AT+CMGW     Write SMS messages     
  AT+CMGD     Delete SMS messages     
             AT+CNMI Notification of newly received SMS                   
  AT+CPBR     Read phonebook entries     
  AT+CPBW     Write phonebook entries     
  AT+CPBF     Search phonebook entries     
  AT+CLCK     Opening or closing facility locks  
  AT+CPWD     Changing passwords     
 
 
  AT+CMEE=n     Enable certain error messages  
  AT+CMGF=1     to operate in SMS text mode   
 AT+CMGF=0     to operate in PDU mode   
AT+CMGL="ALL"    List all the messages     
  AT+CNMA     New message acknowledgement 
 
 
Appendix B SMS Message Format 
 
SMS to be sent in 8-bit octet format, MAX SMS length thus 140 chars 
 
Header (ASCII printable characters) Updated (New) 
 
ModuleID / IV / Type / MeterModel / MeterID / 
5 1 var 1 1 1 var  ~6 1 var ~16 1 
 
 
ModuleID: alphanumeric identifier, 5 characters 
 
IV: empty field for plaintext, hexadecimal number when encrypted 
 
Type:  single character 
G Glucose, mg/dl  (18*mmol/L) 
  
 
Meter Model: abbreviated string 
AssCtr Assensia Contour 
OneTch OneTouchUltra 
FrMini FreeStyle Mini 
CareSN CareSens N 
 
MeterID:  alphanumeric serial number reported by meter 
 
 
 
 
 
Readings (binary data) 
nReadings [ DTG value N times ] (term) 
1 1 4 2  x N 1 
 
Length = 2 + 6N (for N readings) 
 
nReadings:  uint8 value containing the number of readings 1..15 
 
DTG:  uint32 date-time in seconds since 1Jan1970 (unix time) 
 
value:  uint16 reading value (interpretation dependant on format) 
 
term:  char; terminating character, ‘]’ 
 
endpadding: if necessary message may be padded with ASCII 0x00. 
 
 
 
Appendix C 
WithCare+ Patient Reference 
What this system does 
This system comprises an electronic module 
which you connect to your meter with the cable 
provided.  When the app on the mobile phone 
is active and Start button is pressed then with 
the button press on the WithCare+ device it 
sends your readings via your mobile telephone 
using Bluetooth
TM
 to send a Short Message 
Service (SMS) to a remote system which stores 
these results and allows your clinician to access 
them. 
 
Benefits 
This saves your time in having to record results 
and phone them in.  It also automatically 
checks the results against limits defined by 
your doctor both in terms of individual readings 
and two-weekly average.  If anything is 
abnormal it prompts your clinician who may 
contact you directly. 
 
Connecting Your Meter 
Only connect the WithCare+ module using the 
cable provided to the specific meter agreed 
with your clinician.  The cables are uniquely 
configured for each type of meter and must not 
be used with a different meter model.  If you 
need to change meter model stop using the 
WithCare+ device and consult your clinician. 
   For certain meters the module should only be 
plugged in just before sending your readings 
and disconnected shortly afterwards.  Follow 
the instructions provided by your clinician. 
 
Pairing with your phone 
The WithCare+ module is a Bluetooth
TM
 device 
and prior to use must be first “Paired” with 
your mobile telephone.  Your clinician may do 
this for you.   
 
Taking your readings 
Take your readings as instructed by your 
clinician as normal and follow their 
instructions on what to do in the event of high 
or low values.  You may record your readings 
manually if required.  Avoid deleting readings 
from your meters memory as this will prevent 
the WithCare+ module from working. 
 
Sending Readings 
Each time a reading is taken the WithCare+ 
module can be requested to send it to the 
server. Steady amber light indicates the module 
is on but waiting for the button to be pressed 
(1-2 seconds).  It should indicate flashing 
amber whilst searching your meter for results 
and finally a steady green on successful 
sending or red if the process has failed.  If at 
any time it is wished to abort the sending 
process, press and hold the button for 12 
seconds which will power off the module. 
 
Feedback from clinician 
The system gives your clinician a facility to 
quickly text you a message as feedback from 
your results if needed so do not be surprised if 
you receive a text shortly after sending some 
readings or at the start of the day. 
 
 
 
 
Supported Meters 
 
One Touch Ultra Easy 
 
This may be left permanently connected. 
 
 
            CareSens N 
 
This may be left permanently connected. 
 
 
 
 
 
 
 
Bayer Assencia Contour 
 
The correct cable is marked with “1”. 
This may be left permanently connected. 
 
 
 
Operation / Display 
 
Button Press Operation 
short (1-2 seconds) send readings 
long (10 seconds) Pair with phone 
further (long) press turn off module. 
 
Display showing Operation 
 None Module off 
 Amber Waiting for button 
press 
 Flashing 
Amber 
Attempting to read 
meter 
 Alternating 
Red/Green 
Attempting Pairing 
 Flashing 
Green 
Sending data to 
mobile phone 
 
 
 Green Success 
 Red Failure! 
 
Replacement Battery 
 
The battery should last, in normal use, for more 
than a year.  If problems should occur please 
consult your clinician.  The battery should only 
be replaced with a similar AAAA battery.  
Ensure that the orientation is correct (positive + 
and negative - ).  Do not attempt to recharge the 
battery. 
 
Personal Information 
Name  
Mobile No.  
Module ID   ___   ___   ___   ___   ___ 
Module PIN   ___   ___   ___   ___ 
Meter Model  
Meter Serial  
 
 
 
 
 Check that the cable of withcare+ device is attached to glucometer (One Touch 
UltraEasy in our case). 
 Check that Bluetooth is enabled on the phone. If it not ON, please switch Bluetooth 
ON.  
 Start WithCare+ app on the BlackBerry and then press the Start button of withcare+ 
app on the screen. 
 Now press the button on the WithCare+ for 2-3 seconds but not more than 4sec. 
 After that the LED on WithCare+ device will start blinking with Orange color.  
 After few seconds the gluco-meter will show the message PC. This   indicates 
communication is established and everything is going well.  Please continue to wait. 
After some time LED on withcare+ device will start blinking with Green colour. This 
indicates that the mobile phone received the getting records by Bluetooth from the 
gluco-meter device.  
o Then finally 
 The  LED on the device will remain  in Green colour for 5 seconds and 
will automatically  shut-down  
 You should receive message on the mobile phone that message/sms 
has been sent successfully. 
 
Possible errors: 
 If blinking for 5 seconds in Red colour occurs before the shut-down of the WithCare+ 
device then probably it was never paired before and need to be paired first with some 
mobile phone. 
 If LED on device will remain in Red colour for 5 seconds which indicates the error 
has occurred in transmission.  
o Then SMS was not sent successfully. In this case check your mobile phone 
have signal from the GSM network. Or maybe if you are as “Pay as you go 
customer”  check that you have enough credit on the mobile phone. 
o Check that Bluetooth  is enabled on your mobile. 
o  
o Check that you have started the WithCare+ app and pressed on Start button. 
If none of the above was the issue, then please contact the nurse. There many 
other possible error which may indicate that such as low battery on the gluco-
meter or on the WithCare+ device. 
 If for some reason you press the button for more than 5sec then you will see the 
blinking of RED and Green colour for 1min. which indicates you accidently enabled 
the Pairing process. Wait till blinking stops and device shuts down and try again. 
Nothing bad will happen. Just try to avoid pressing the button for more than 4seconds, 
because pairing process consume battery resources which are not unlimited. 
  
 
 
Appendix D Code for Proof of Concept for Establishing Bluetooth Communication 
The following are main steps for establishing Bluetooth Communication between Android 
phone and a Bluetooth enabled device. 
1. Setting up Bluetooth 
2. Finding available devices 
3. Pairing the devices 
4. Connecting the devices 
5. Transferring data between the devices. 
The classes and interfaces needed for accomplishing the above tasks are available in the 
‘android.bluetooth’ package. These classes extend from ‘java.lang.Object’ class of Java API 
and their brief summary is given below: 
BluetoothAdapter: This class is the entry-point for all Bluetooth communication and 
represents the local Bluetooth radio. It can be utilized to find available Bluetooth devices, 
query a paired device, instantiate a BluetoothDevice, and create a socket connection for 
listening.  
BluetoothDevice: This class implements ‘android.os.Parcelable’ interface. It emulates the 
remote Bluetooth device and is used to request a connection to it. This class is used to find 
the information about the remote device such as its name and address. 
BluetoothSocket: This class implements ‘java.io.Closeable’ interface. It acts as a connection 
point for data exchange between Bluetooth devices via OutputStream and InputStream.  
 
 
BluetoothServerSocket: This class also implments ‘java.io.Closeable’ interface. It listens for 
incoming requests as it represents an open server socket and returns a connected 
BluetoothSocket on accepting the connection from a remote Bluetooth device.  
BluetoothClass: This class implements ‘android.os.Parcelable’ interface. It describes general 
capabilities of a Bluetooth device but does not describe all services and Bluetooth profiles 
supported by the device reliably. 
Bluetooth Permissions:  For any kind of Bluetooth communication between devices it is 
essential to set up permissions in the manifest file of an application.  A constant value 
represented by ‘android.permission.BLUETOOTH’ must be declared in the manifest file and 
the application must request Bluetooth permission in order to establish any communication 
such as requesting or accepting a connection, and transferring data. In order to initiate device 
discovery or manipulate Bluetooth settings, an application must request ‘android.permission. 
BLUETOOTH_ADMIN’ and it should be declared in the manifest file of the application as 
well. 
1 Setting up Bluetooth 
The first step for an application to set up Bluetooth communication is to ensure that the 
device supports the Bluetooth and if it does, then it should make sure it is enabled. If the 
device does not support Bluetooth, in that case the application should gracefully exit. 
However, if Bluetooth is supported but disabled, then the application should request the user 
to enable Bluetooth without leaving the application.  
This setup is done in two steps, using the getDefaultAdapter() method of  BluetoothAdapter 
class. The code snippet for this operation is shown below: 
BluetoothAdapter mBluetoothAdapter= BluetoothAdapter.getDefaultAdapter( ); 
If (mBluetoothAdapter == null) { 
 
 
 // if the object value is null, the device does not support Bluetooth. 
} 
getDefaultAdapter() is a static method and returns a handle to the Bluetooth of the remote 
device if it exists but it returns a null if the device does not support Bluetooth and in this case 
the application should gracefully exit.  
2 Enable Bluetooth 
This step is accomplished by calling isEnabled() method of the BluetoothAdapter handle 
returned in step 1. If the return value of this method is false, then Bluetooth is not enabled. 
This can be enabled by calling startActivityForResult() method with the  
ACTION_REQUEST_ENABLE action Intent. This will request to enable Bluetooth through 
the system settings without stopping the application. The code snippet for this action is 
below: 
 if (!mBluetoothAdapter.isEnabled()) { 
     Intent enableBtIntent = new 
Intent(BluetoothAdapter.ACTION_REQUEST_ENABLE); 
     startActivityForResult(enableBtIntent, REQUEST_ENABLE_BT); 
 } 
The above code snippet will create a dialog requesting the user to enable Bluetooth as shown 
in figure 1. 
 
 
 
           Figure 1 Bluetooth Permission request  
If the user clicks on the ‘Yes’ button, the system will start enabling Bluetooth and focus will 
return to the application after the process is completed either with success or failure. In the 
code snippet above, REQUEST_ENABLE_BT (a locally defined constant greater than 0) is 
passed to startActivityForResult() method , that the system passes back to onActivityResult() 
callback method as the requestCode parameter. The value of this parameter will be 
RESULT_OK if the user clicks on the ‘Yes’ button or RESULT_CANCELLED if the user 
clicks on the ‘No’ button. 
The application can also detect changes made to the Bluetooth state while it is running by 
listening to the ACTION_STATE_CHANGED broadcast Intent, which will be broadcast by 
the system whenever the Bluetooth state changes. There are two fields EXTRA_STATE and 
EXTRA_PREVIOUS_STATE, which contain the new and old Bluetooth states, respectively. 
The possible values for these two fields are STATE_TURNING_ON, STATE_ON, 
STATE_TURNING_OFF and STATE_OFF. 
3 Finding Devices 
The BluetoothAdapter class can be used through device querying paired devices or the 
discovery method for finding the available remote Bluetooth devices. In the device discovery 
method, the application searches the local area for Bluetooth enabled devices and the devices 
which are currently enabled to be discoverable respond back to the discovery request by 
sharing some information such as their name and unique media access control (MAC) 
address. The application can then choose to initiate a connection to the discovered device. If 
the connection is made with a remote device for the first time, a pairing request is 
automatically presented to the user. The basic information such as name and MAC address of 
the remote device is saved by the application after a device is paired and can be retrieved by 
Bluetooth APIs.  The saved MAC address of the remote device can be used by the application 
 
 
to initiate connection at any time in the future without performing the device discovery step 
again (assuming the remote device is within the Bluetooth range). There is a difference 
between being paired and being connected. When two devices are paired that means they are 
aware of the existence of each other and are ready to establish an encrypted connection with 
each other, Whereas the connected devices share an RFCOMM channel and can send data to 
each other. The next section describes how to find already paired devices using the Bluetooth 
API. 
4 Querying Paired Devices 
The BluetoothAdapter has a getBondedDevices method which can be used to query the 
paired devices. This method when called returns a Set of BluetoothDevices representing 
paired devices. The code snippet below shows how the application can use this method to get 
a Set of BluetoothDevices representing paired devices and then show the name of each device 
to the user, using an ArrayAdapter object. 
Set<BluetoothDevice> pairedDevices = mBluetoothAdapter.getBondedDevices(); 
// If there are paired devices 
if (pairedDevices.size() > 0) { 
    // Loop through paired devices 
    for (BluetoothDevice device : pairedDevices) { 
        // Add the name and address to an array adapter to show in a ListView 
        mArrayAdapter.add(device.getName() + "\n" + device.getAddress()); 
    } 
} 
 
 
The MAC address of remote device can be later used to initiate the connection to it, which 
will be explained in the next section. 
5 Connecting Devices 
The two devices are considered connected to each other when they each have a connected 
BluetoothSocket on the same RFCOMM channel. The connection with a remote device can 
be initiated with a BluetoothDevice object that represents the remote section as explained in 
the Finding Devices section. There are two steps involved in establishing the connection. 
1. Call the method createRfcommSocketToServiceRecord( UUID) of BluetoothDevice to 
acquire a BluetoothSocket and initiate the connection. The UUID (universal unique 
identifier) is a string which can be generated online by any of the available engines. The same 
UUID should be used both on the server and the client for the application. 
2. Call connect () method. This call will perform an service discovery protocol (SDP) lookup 
on the remote device in order to match the UUID. The RFCOMM channel will be shared if 
the lookup is successful and the remote device accepts the connection and the connect () 
method will return. This step should always be performed in a thread safe manner as if for 
any reason the method call fails or times out after 12 seconds, it will throw an exception. 
6 Managing a Connection 
Now the devices are connected and the data can be transferred between the devices using a 
BluetoothSocket. The methods of java.io package can be used to transfer data as below: 
1. getInputStream and getOutputStream methods can be used to get InputStream and 
OutPutStream objects to transfer the data. 
2. The data is then written using the read (byte [ ]) and write (byte[ ] ) methods. The read and 
write methods should be used in the dedicated threads as they are blocking methods.  
 
 
The application developed using this procedure was installed on an Android phone and data 
was written to a PSoC development kit to prove that it is possible to establish the 
communication over the RFCOMM if the SPP is blocked by the operating system. The 
following code snippet shows how data can be written to a remote device. 
/* Call this from the main activity to send data to the remote device */ 
    public void write(byte[] bytes) { 
        try { 
            mmOutStream.write(bytes); 
        } catch (IOException e) { } 
    } 
 
 
 
